☐ | Preliminary Proxy Statement | ||||
☐ | Confidential, for Use of the SEC Only (as permitted by Rule 14a-6(e)(2)) | ||||
☒ | Definitive Proxy Statement | ||||
☐ | Definitive Additional Materials | ||||
☐ | Soliciting Material Pursuant to 14a-12 | ||||
☒ | No fee required | ||||
☐ | Fee paid previously with preliminary materials | ||||
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 | ||||
 | Warm regards, /s/ Margaret M. FitzPatrick, M.A. Margaret M. FitzPatrick, M.A. Board Chair | ||||
| 1. | to elect six directors to our Board of Directors, each to serve until our next annual meeting of stockholders, or until her or his respective successor is elected and qualified; | |||||||
| 2. | to approve, on a non-binding advisory basis, the compensation paid to our Named Executive Officers (NEOs); | |||||||
| 3. | to ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2026; and | |||||||
| 4. | to vote upon such other matters, if any, as may properly come before the Annual Meeting or any adjournment or postponement of the Meeting. | |||||||
YOUR VOTES ARE IMPORTANT All stockholders are cordially invited to attend the Annual Meeting virtually. However, to ensure your representation at the Annual Meeting, you are urged to vote by Internet, telephone or postal mail in advance of the Meeting, as promptly as possible. Submitting your votes in advance of the Annual Meeting assures that a quorum will be present at the Meeting and will avoid the Company from incurring additional expense for duplicate proxy solicitations. By following the procedures described in the section entitled “Voting” beginning on page 3 of the attached Proxy Statement, any stockholder attending the Annual Meeting virtually may vote at the Meeting, even if he or she has returned a proxy prior to the Meeting. | ||||||||
| By Order of the Board of Directors, | |||||
| /s/ Jessica R. Haskell, J.D. | |||||
| Jessica R. Haskell, J.D. | |||||
| Associate General Counsel and Corporate Secretary | |||||
| Record Date and Shares Outstanding | Each of the specific proposals to be considered and acted upon at the Annual Meeting is described in this Proxy Statement. Only holders of Vistagen's common stock as of the close of business on July 16, 2025 (the Record Date) are entitled to notice of and to vote at the Annual Meeting. On the Record Date, there were 29,859,961 shares of our common stock, par value $0.001 per share, outstanding. Each holder of our common stock is entitled to one vote for each share held as of the Record Date. | |||||||
| Quorum | The holders of more than one-third (1/3) of the shares of our common stock entitled to vote as of the Record Date must be represented at the Annual Meeting, either in person or by properly executed proxy, to achieve a quorum for the Meeting. If a quorum is not present at the scheduled time of the Annual Meeting, either the Chair of the Meeting or the stockholders who are present may adjourn the Annual Meeting until a quorum is present. If necessary, the time and place of the adjourned Annual Meeting will be announced at the time the adjournment is taken, and no other notice will be given. An adjournment will have no effect on the business that may be conducted at the Annual Meeting. | |||||||
| Stockholder List | A list of registered stockholders as of the close of business on the Record Date will be open for examination by any stockholder for a period of ten days prior to the Annual Meeting for a purpose pertaining to the Meeting by sending an email to corp.secretary@vistagen.com, stating the purpose of the request and providing proof of ownership of our common stock. This list will also be available for examination by stockholders of record during the Annual Meeting webcast at: https://meetnow.global/MMRS64D | |||||||
| Attendance at Virtual Annual Meeting | We will host the Annual Meeting live and only online, via Internet webcast. You may attend the Annual Meeting virtually by visiting the following web address: https://meetnow.global/MMRS64D The Annual Meeting webcast will start at 9:00 am Pacific Daylight Time, on September 9, 2025. | |||||||
To attend the Annual Meeting virtually please go to https://meetnow.global/MMRS64D. You have the option to log in to the Annual Meeting as a “stockholder” with a control number or as a “guest.” If you are a stockholder of record (i.e., if you hold your shares through Computershare, our registrar and transfer agent), you may log in to the Annual Meeting as a stockholder using the control number which can be found on your Notice and proxy card. If you are not a stockholder of record (i.e. if you do not hold your shares through Computershare), but hold shares through an intermediary, such as a bank or broker, trustee or nominee (sometimes referred to as holding in “street name”), you may attend the Annual Meeting as “guest” by entering your name and email address. As a guest, you will have access to the Annual Meeting materials and will be able to ask questions during the Annual Meeting, but you will not be able to vote during the Meeting. If you hold your shares through an intermediary, such as a bank or broker, and you desire to vote during the Annual Meeting, you must register in advance to attend the Meeting virtually as a stockholder. To register to attend the Annual Meeting virtually as a stockholder, you must provide proof of beneficial ownership as of the Record Date, such as an account statement, legal proxy from your broker, or similar evidence of ownership along with your name and email address to Computershare. Requests for Annual Meeting registration of beneficial owners must be labeled as “Legal Proxy” and be received no later than 5:00 p.m., Eastern Daylight Time, on September 2, 2025. You will receive confirmation of your Annual Meeting registration by email after Computershare receives your registration materials. Requests for registration should be directed by email to legalproxy@computershare.com or by mail to Computershare, Vistagen Therapeutics, Inc. Legal Proxy, P.O. Box 43001, Providence, RI 02940-3001. You will receive a confirmation email from Computershare of your Annual Meeting registration and will receive a control number to enter the Meeting as a stockholder. Whether you attend the Annual Meeting virtually as a stockholder or as a guest, please allow yourself ample time for the online check-in procedures. | ||||||||
| Questions at the Annual Meeting | If you wish to submit a question during the Annual Meeting, you may log in online, and ask a question on our virtual Annual Meeting platform at: https://meetnow.global/MMRS64D Our Annual Meeting will be governed by our Rules of Conduct which will be available on the virtual Meeting platform during the Meeting. The Rules of Conduct will address the ability of stockholders to ask questions during the Annual Meeting, including rules on permissible topics, and rules for how questions and comments will be recognized and disclosed to Meeting participants. | |||||||
| Voting | There are four ways a stockholder of record can vote: (1) By Internet: If you are a stockholder as of the Record Date, you may vote over the Internet by following the instructions provided in the Notice. (2) By Telephone: If you are a stockholder as of the Record Date, you may vote by telephone by following the instructions in the Notice. (3) By Mail: If you requested printed copies of proxy materials and are a stockholder as of the Record Date, you may vote by mailing your proxy as described in the proxy materials. (4) During the Annual Meeting: The Annual Meeting will be held exclusively virtually via the Internet, and can only be accessed at: https://meetnow.global/MMRS64D Subject to the provisions applicable to other than holders of record as outlined above in the section entitled “Attendance at Annual Meeting,” if you are a stockholder as of the Record Date, you will have the ability to attend the Annual Meeting and vote online during the Meeting. Submitting a proxy will not prevent a stockholder from attending the Annual Meeting virtually, revoking an earlier-submitted proxy in accordance with the process outlined below and voting online during the Meeting. | |||||||
In order to be counted, proxies submitted by telephone or via the Internet must be received by 11:59 p.m., Eastern Daylight Time, on September 8, 2025. Proxies submitted by U.S. mail must be received before the start of the Annual Meeting. If you hold your shares through a bank or broker, please follow their voting instructions. | ||||||||
| Required Vote for Approval and Board Recommendation | Proposal No. 1: Election of Directors. Directors are elected by a plurality vote of the votes cast, either in person or represented by proxy, and entitled to vote at the Annual Meeting. The six director nominees who receive the greatest number of “FOR” votes cast at the Annual Meeting by the shares present, either in person or by proxy, and entitled to vote will be elected to serve on our Board of Directors until our next annual meeting of stockholders, or until her or his successor is duly elected and qualified. Our Board unanimously recommends a vote “FOR” the election of each of our six director nominees, all of whom currently serve on our Board of Directors. Unless otherwise instructed or unless authority to vote is withheld, shares represented by executed proxies will be voted “FOR” the election of each of the six nominees. | |||||||
Proposal No. 2: Approval, on a Non-Binding Advisory Basis, of the Compensation Paid to our Named Executive Officers. This proposal calls for a non-binding, advisory vote regarding the compensation paid to our Named Executive Officers (NEOs) (Say-on-Pay). Accordingly, there is no required vote that would constitute approval of this proposal. However, our Board, including the Compensation Committee of our Board, values the opinions of our stockholders and will consider the result of the vote when making future decisions regarding our executive compensation policies and practices. The affirmative “FOR” vote of a majority of the votes cast, in person or by proxy, excluding abstentions, is required to approve this non-binding, advisory proposal. Our Board unanimously recommends a vote “FOR” this proposal. Unless otherwise instructed or unless authority to vote is withheld, shares represented by executed proxies will be voted “FOR” the approval of this non-binding, advisory proposal. | ||||||||
Proposal No. 3: Ratification of Appointment of our Independent Registered Public Accounting Firm. This proposal requests stockholders to ratify the appointment of KPMG LLP as our independent registered public accounting firm for our current fiscal year ending March 31, 2026. The affirmative “FOR” vote of a majority of the votes cast, either in person or by proxy at the Annual Meeting, excluding abstentions, is required for the ratification of the selection of KPMG LLP as our independent registered public accounting firm for our current fiscal year ending March 31, 2026. Our Board unanimously recommends a vote “FOR” this proposal. Unless otherwise instructed or unless authority to vote is withheld, shares represented by executed proxies will be voted “FOR” the ratification of the selection of KPMG LLP as our independent registered public accounting firm for our current fiscal year ending March 31, 2026. | ||||||||
| Abstentions and Broker Non-Votes | All votes will be tabulated by the inspector of election appointed for the Annual Meeting, who will separately tabulate affirmative and negative votes, abstentions and broker non-votes. An abstention (or a vote to “WITHHOLD” for purposes of the election of directors) is the voluntary act of not voting by a stockholder who is present at a meeting and entitled to vote. A broker “non-vote” occurs when a broker nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary power for that particular item and has not received instructions from the beneficial owner. If you hold your shares in “street name” through a broker, brokerage firm or other nominee, your broker, brokerage firm or nominee may not be permitted to exercise voting discretion with respect to some of the matters to be acted upon. If you do not give your broker, brokerage firm or nominee specific instructions regarding such matters, your proxy will be deemed a “broker non-vote.” As noted above, the six director nominees identified under Proposal No. 1 who receive the most “FOR” votes at the Annual Meeting will be elected to serve on our Board of Directors until our next annual meeting of stockholders, or until her or his successor is duly elected and qualified. As such, we expect that votes marked “WITHHOLD” and broker non-votes will have no effect on the outcome of Proposal No. 1. Under Nevada law and our Second Amended and Restated Bylaws, as amended (our Bylaws), Proposal Nos. 2 and 3 will each be determined by the vote of the holders of a majority of the votes cast by those present at the Annual Meeting or by proxy (meaning the number of shares voted “FOR” a proposal must exceed the number of shares voted “AGAINST” each such proposal). For these matters, we expect that abstentions and any broker non-votes cast will not be counted as votes in favor of such proposals and will also not be counted as shares voting on such matters, but will be considered shares present at the Meeting for purposes of establishing a quorum. As such, we expect that abstentions and broker non-votes will have no effect on Proposal Nos. 2 and 3. | |||||||
| Revocation of Proxies | You may revoke or change your proxy at any time before the Annual Meeting by filing, with our Corporate Secretary at our principal executive offices, located at 343 Allerton Avenue, South San Francisco, California 94080, a notice of revocation or another signed proxy with a later date. You may also revoke your proxy by virtually attending the Annual Meeting and voting at the Meeting. Your virtual attendance at the Annual Meeting will not, by itself, revoke your proxy. | |||||||
| Solicitation | We will bear the entire cost of solicitation, including the preparation, assembly, printing and mailing of the Notice, as well as the preparation and posting on the Internet of this Proxy Statement and any additional solicitation materials furnished to the stockholders. We have retained Saratoga Proxy Consulting, LLC, a proxy soliciting firm, to assist with the solicitation of proxies for a fee of approximately $10,000 plus fees for any retail stockholder outreach services and reimbursement for out-of-pocket expenses. Copies of any solicitation materials will be furnished to brokerage houses, fiduciaries and custodians holding shares in their names that are beneficially owned by others so that they may forward the solicitation materials to such beneficial owners. In addition, we may reimburse such persons for their costs in forwarding the solicitation materials to such beneficial owners. The original solicitation of proxies may be supplemented by a solicitation, by telephone, email or other means, by our directors, officers or employees. No additional compensation will be paid to these individuals for any such services. Except as described above, we do not presently intend to solicit proxies other than by the Internet, telephone, email and postal mail. | |||||||
Margaret M. FitzPatrick, M.A. Chair and Independent Director | Mary L. Rotunno, J.D. Independent Director | ||||
Ann M. Cunningham, MBA Non-Independent Director | Jon S. Saxe, J.D., LL.M. Independent Director | ||||
Joanne Curley, Ph.D. Independent Director | Shawn K. Singh, J.D. President, Chief Executive Officer and Director | ||||
| Ms. FitzPatrick has served on our Board of Directors since July 2021, and as Chair since October 2023. Ms. FitzPatrick is the Founder of FitzPatrick & Co., LLC, a business advisory firm founded in July 2020. Prior to the founding of FitzPatrick & Co. LLC, Ms. FitzPatrick served as Senior Vice President, Corporate Affairs, Philanthropy and Customer Engagement at Exelon Corporation (Nasdaq: EXC), a diversified clean energy company, from 2016 to 2020, as Global Chief Communications Officer at Johnson & Johnson (NYSE: JNJ), one of the largest and most broadly-based healthcare companies, from 2013 to 2016, as Global Chief Communication Officer and President of the Foundation at CIGNA from 2010 to 2013. Ms. FitzPatrick also served as Executive Vice President at APCO Worldwide, a global public affairs and strategic communications consultancy, where she counseled executives on major global reputation efforts for notable industry leaders. Ms. FitzPatrick currently serves on the board of directors of AN2 Therapeutics, Inc. (Nasdaq: ANTX), where she is lead independent director and a member of the Nominating and Corporate Governance Committee. Ms. FitzPatrick holds a B.A. in English and Policy Studies from Syracuse University, and an M.A. in Public Policy from The George Washington University. In 2018, she completed the Harvard Business School program for corporate directors. She is a National Association of Corporate Directors (NACD) Certified Director and a faculty member of NACD's Board Advisory Services. We selected Ms. FitzPatrick to serve as Chair of our Board due to her extensive experience in corporate governance and leadership at some of the world's most successful companies. The Board believes Ms. FitzPatrick’s expertise in healthcare and her work in the global pharmaceutical market provides valuable contributions as the Company continues to advance the development of its product candidates to address unmet patient needs. | |||||||
Margaret M. FitzPatrick, M.A. Chair and Independent Director Age 59 | ||||||||
 | Ms. Cunningham has served as a member of our Board since January 2019 and served as the Company's Chief Commercial Officer from May 2021 to November 2022. Currently, Ms. Cunningham is the Founder and Managing Partner of i3 Strategy Partners, a consulting firm founded in 2018 specializing in assisting companies in the pharmaceutical space. Prior to founding i3 Strategy Partners, Ms. Cunningham served as Vice President, Neurodegenerative Diseases and Psychiatry for Teva Pharmaceuticals Industries, Ltd. (NYSE: TEVA) from 2015 to 2018, as Senior Marketing Director for Otsuka Pharmaceutical Companies from 2013 to 2015 and in several marketing-focused positions for Eli Lily and Company (NYSE: LLY) from 1999 to 2013, including serving as Global Marketing Senior Director from 2009 to 2013. Ms. Cunningham holds a B.A. in Psychology from Yale University and a MBA, with a focus on marketing management, from the University of Michigan. We selected Ms. Cunningham to serve on our Board due to her substantial experience in healthcare commercialization and marketing, particularly in the successful development, positioning and commercial launch of products to treat neuropsychiatric disorders. Ms. Cunningham brings an insightful commercial perspective to us and to our Board that is critical as our pipeline products move from clinical development to commercialization. | |||||||
Ann M. Cunningham, MBA Non-Executive, Non-Independent Director Age 57 | ||||||||
 | Dr. Curley has served as a member of our Board of Directors since April 2021. Dr. Curley brings more than 25 years of experience in the development and commercialization of pharmaceutical products, including research and development governance. From March 2020 until her retirement in October 2023, Dr. Curley served as the Chief Development Officer at Vera Therapeutics, Inc. (Nasdaq: VERA). Prior to joining Vera Therapeutics, from June 2005 to March 2020, Dr. Curley held various director-level positions with Gilead Sciences, Inc. (Nasdaq: GILD), during which time the anti-viral portfolio grew from four to seventeen commercial products. While at Gilead, Dr. Curley led Project and Portfolio Management with oversight of the development pipeline across four therapeutic areas and was responsible for research and development governance. Before Gilead, Dr. Curley worked as an aerosol formulation scientist and subsequently as a project leader at Nektar Therapeutics (Nasdaq: NKTR). Dr. Curley received a B.Sc in Physics and Chemistry from Trinity College, Ireland, a Ph.D. in Polymer Science and Engineering from the University of Massachusetts, Amherst and completed a post-doctorate at Massachusetts Institute of Technology and Harvard Medical School, focused on long-acting biodegradable formulations. We selected Dr. Curley to serve on our Board due to her extensive experience in early product development, regulatory approval and commercialization of pharmaceutical products, giving her a unique perspective of the life cycle of drug development. | |||||||
Joanne Curley, Ph.D. Independent Director Age 57 | ||||||||
 | Mr. Saxe has served as a director on our Board since 2000, and served as Chair of our Board until October 2023. He currently serves as the Chair of our Audit Committee. Mr. Saxe is the retired President and was a director of PDL BioPharma from 1989 to 2008. From 1989 to 1993, he was President, Chief Executive Officer and a director of Synergen, Inc. (acquired by Amgen). Mr. Saxe served as Vice President, Licensing & Corporate Development for Hoffmann-Roche from 1984 through 1989, and Head of Patent Law for Hoffmann-Roche from 1978 through 1989. Mr. Saxe currently is the lead director of K2x Technology and Life Sciences, is Chair of the board of directors of Epalex Corporation, and serves as a director of five additional private life science companies, Aether, Inc., Achelios Therapeutics, Inc., Arbor Vita Corporation, NuvOx Pharma, LLC and Trellis Bioscience, Inc. In addition, Mr. Saxe serves as a board observer of InGeneron, Inc. and Renexxion, Inc. Mr. Saxe has also served as a director of other biotechnology and pharmaceutical companies, including ID Biomedical (acquired by GlaxoSmithKline), Sciele Pharmaceuticals, Inc. (acquired by Shionogi), Amalyte (acquired by Kemin Industries), Cell Pathways (acquired by OSI Pharmaceuticals), Lumos Pharma, Inc. (merged with New Link Genetics) and other companies, both public and private. Mr. Saxe has a B.S.Ch.E. from Carnegie-Mellon University, a J.D. degree from George Washington University and an LL.M. degree from New York University. In addition, Mr. Saxe has a Certificate in Management from Fuqua School of Business, Duke University. We selected Mr. Saxe to serve as a director on our Board of Directors due to his numerous years of experience as a senior executive with major pharmaceutical and biotechnology companies, including Protein Design Labs, Inc., Synergen, Inc. and Hoffmann-Roche, Inc., as well as his extensive experience serving as a director of numerous private and public biotechnology and pharmaceutical companies, serving as Chairman, and Chair and member of audit, compensation and governance committees of both private and public companies. Mr. Saxe provides us and our Board of Directors with highly valuable insight and perspective into the biotechnology and pharmaceutical industries, as well as the strategic opportunities and challenges that we face. | |||||||
Jon S. Saxe, J.D., LL.M. Independent Director Age 89 | ||||||||
 | Ms. Rotunno has served as a member of our Board since July 2021. Prior to her retirement in March 2024, Ms. Rotunno served as General Counsel of El Camino Health, a health care system, since January 2014, and as a Member of the Executive Leadership Team at El Camino Health since August 2015. Ms. Rotunno is also Chair of the Compensation Committee for healthcare provider Momentum for Health, located in San Jose, California. Before joining El Camino Health, Ms. Rotunno spent over 11 years as Senior Counsel and Client Service Leader for Common Spirit Health, formerly Dignity Health, in California’s San Francisco Bay Area. Prior to Dignity Health, she held various legal roles at Varian Medical Systems, Manatt, Phelps & Phillips, Golden Living, and Pillsbury Winthrop Shaw Pitman. Ms. Rotunno graduated with honors from the University of Illinois with a B.S. in Nursing. She worked as a registered nurse before earning her J.D. degree, cum laude, from the University of California, Hastings College of Law, San Francisco. She obtained certification by the NACD, Stanford Directors College, the Women’s Corporate Board Readiness Program at Santa Clara University and completed the Hastings Leadership Academy for Women and Dignity Health Ministry Leadership Program. We selected Ms. Rotunno to serve on our Board due to her extensive experience as an advocate for both patients and healthcare providers and her insights into strategies for value-based care and an understanding of the life cycle of the mental healthcare experience. Ms. Rotunno also brings insights on complex governance, regulatory and compliance requirements to complement her strategic vision and skills for scenario planning and enterprise risk management. | |||||||
Mary L. Rotunno, J.D. Independent Director Age 65 | ||||||||
 | Mr. Singh has served as our Chief Executive Officer and as a member of our Board since August 2009, and as President since December 2024. Mr. Singh has over 30 years of experience working with biotechnology, medical device and pharmaceutical companies, both private and public. From 2001 to August 2009, Mr. Singh served as Managing Principal of Cato BioVentures, a life science venture capital firm, and as Chief Business Officer and General Counsel of Cato Research Ltd (now Allucent), a contract research organization (CRO) previously affiliated with Cato BioVentures. Mr. Singh served as President (part-time) of Echo Therapeutics, a medical device company, from 2007 to 2009, and as a member of its board of directors from 2007 to 2011. He also served as Chief Executive Officer (part-time) of Hemodynamic Therapeutics, a private biopharmaceutical company previously affiliated with Cato BioVentures, from 2004 to 2009. From 2000 to 2001, Mr. Singh served as Managing Director of Start-Up Law, a management consulting firm serving biotechnology companies. Mr. Singh also served as Chief Business Officer of SciClone Pharmaceuticals (formerly Nasdaq: SCLN), a specialty pharmaceutical company, from 1993 to 2000, and as a corporate finance associate of Morrison & Foerster LLP, an international law firm, from 1991 to 1993. Mr. Singh earned a B.A., with honors, from the University of California, Berkeley, and a J.D. from the University of Maryland School of Law. Mr. Singh is a member of the State Bar of California. We selected Mr. Singh to serve on our Board due to his substantial practical experience and expertise in multiple senior leadership roles with private and public biotechnology, pharmaceutical and medical device companies, and his extensive experience in corporate finance and capital markets, venture capital, corporate governance, drug development, intellectual property, regulatory affairs and strategic collaborations. | |||||||
Shawn K. Singh, J.D. Chief Executive Officer and Director Age 62 | ||||||||
Current Schedule of Director Fees During Fiscal 2024 Effective January 1, 2024 | |||||||||||||||||
| Description | Cash(1)($) | Equity(2) | |||||||||||||||
| Director Annual Retainer | $ | 50,000 | Non-executive members of our Board will be entitled to the following equity awards: (i) a one-time grant of stock options upon appointment to the Board equal to 2x the annual grant otherwise payable to directors, and (ii) an annual grant of stock options equal to 0.046% of the Company's issued and outstanding common stock on the grant date. Annual awards will be granted to directors following the Company's annual meeting of stockholders. | ||||||||||||||
| Additional fee for Board Chair | $ | 30,000 | |||||||||||||||
| Audit Committee | |||||||||||||||||
| Chair | $ | 20,000 | |||||||||||||||
| Member | $ | 10,000 | |||||||||||||||
| Compensation Committee | |||||||||||||||||
| Chair | $ | 10,000 | |||||||||||||||
| Member | $ | 5,000 | |||||||||||||||
| Corporate Governance and Nominating Committee | |||||||||||||||||
| Chair | $ | 10,000 | |||||||||||||||
| Member | $ | 5,000 | |||||||||||||||
(1) | Cash fees payable in quarterly installments. | ||||
(2) | All Awards issued pursuant to the Director Compensation Plan will be issued pursuant to the 2019 Plan or a successor plan, if any. Each Award issued under the Director Compensation Plan will vest in equal monthly installments over a 12-month period beginning on the date of issuance. | ||||
| Name | Fees Paid in Cash(1) | Option Awards(2)(3) | Other Compensation | Total | ||||||||||||||||||||||||||||||||||
Margaret M. FitzPatrick, M.A.(4) | $ | 90,000 | $ | 43,726 | $ | — | $ | 133,726 | ||||||||||||||||||||||||||||||
Ann M. Cunningham, MBA(5) | $ | 52,500 | $ | 43,726 | $ | — | $ | 96,226 | ||||||||||||||||||||||||||||||
Joanne Curley, Ph.D.(6) | $ | 55,000 | $ | 43,726 | $ | — | $ | 98,726 | ||||||||||||||||||||||||||||||
Jerry B. Gin, Ph.D., MBA(7) | $ | 70,000 | $ | 43,726 | $ | — | $ | 113,726 | ||||||||||||||||||||||||||||||
Mary L. Rotunno, J.D.(8) | $ | 70,000 | $ | 43,726 | $ | — | $ | 113,726 | ||||||||||||||||||||||||||||||
Jon S. Saxe, J.D., LL.M.(9) | $ | 75,000 | $ | 43,726 | $ | — | $ | 118,726 | ||||||||||||||||||||||||||||||
(1) | The amounts shown in the table above represent fees earned for service on our Board, as well as service on our Audit Committee, Compensation Committee and/or Corporate Governance and Nominating Committee during Fiscal 2025, as applicable, which amounts were paid in full during Fiscal 2025. | ||||
(2) | The amounts shown in the “Option Awards” column do not represent any cash payments actually received by Ms. FitzPatrick, Ms. Cunningham, Dr. Curley, Dr. Gin, Ms. Rotunno or Mr. Saxe during Fiscal 2025. Rather, the amounts shown represent the aggregate grant date fair value of options to purchase shares of our common stock awarded to each of Ms. FitzPatrick, Ms. Cunningham, Dr. Curley, Dr. Gin, Ms. Rotunno or Mr. Saxe during Fiscal 2025, computed in accordance with Financial Accounting Standards Board’s Accounting Standards Codification Topic 718, Compensation – Stock Compensation (ASC 718). To date, Ms. FitzPatrick, Ms. Cunningham, Dr. Curley, Dr. Gin, Ms. Rotunno or Mr. Saxe have not exercised any of the options granted during Fiscal 2025, and there can be no assurance that any of them will ever realize all or any portion of the full ASC 718 grant date fair value amounts presented above in the “Option Awards” column. | ||||
(3) | The table below provides information regarding the option awards we granted to our independent Board members, as well as to Ms. Cunningham, who is a non-executive, non-independent member of our Board, during Fiscal 2025 and the weighted average assumptions used in the Black Scholes Option Pricing Model to determine the grant date fair values of the respective awards. | ||||
| Option Grant | ||||||||||||||||||||||||||
| 9/6/2024 | Total | |||||||||||||||||||||||||
| Option Shares Granted | ||||||||||||||||||||||||||
| Ms. FitzPatrick | 14,100 | 14,100 | ||||||||||||||||||||||||
| Ms. Cunningham | 14,100 | 14,100 | ||||||||||||||||||||||||
| Dr. Curley | 14,100 | 14,100 | ||||||||||||||||||||||||
| Dr. Gin | 14,100 | 14,100 | ||||||||||||||||||||||||
| Ms. Rotunno | 14,100 | 14,100 | ||||||||||||||||||||||||
| Mr. Saxe | 14,100 | 14,100 | ||||||||||||||||||||||||
| Option Award Compensation | ||||||||||||||||||||||||||
| Ms. FitzPatrick | $ | 43,726 | $ | 43,726 | ||||||||||||||||||||||
| Ms. Cunningham | $ | 43,726 | $ | 43,726 | ||||||||||||||||||||||
| Dr. Curley | $ | 43,726 | $ | 43,726 | ||||||||||||||||||||||
| Dr. Gin | $ | 43,726 | $ | 43,726 | ||||||||||||||||||||||
| Ms. Rotunno | $ | 43,726 | $ | 43,726 | ||||||||||||||||||||||
| Mr. Saxe | $ | 43,726 | $ | 43,726 | ||||||||||||||||||||||
| Option Award Assumptions | ||||||||||||||||||||||||||
| Exercise price | $ | 3.25 | ||||||||||||||||||||||||
| Grant date market price | $ | 3.25 | ||||||||||||||||||||||||
| Risk free interest rate | 3.49 | % | ||||||||||||||||||||||||
| Expected term (years) | 5.20 | |||||||||||||||||||||||||
| Volatility | 131.73 | % | ||||||||||||||||||||||||
| Dividend Rate | 0.00 | % | ||||||||||||||||||||||||
| Fair Value per share | $ | 3.1 | ||||||||||||||||||||||||
| Aggregate option shares | 84600 | |||||||||||||||||||||||||
(4) | Ms. FitzPatrick was appointed to our Board in July 2021 and was appointed to serve as Chair of our Board in October 2023, Ms. FitzPatrick has also served as a member of our Corporate Governance and Nominating Committee since her appointment. On November 21, 2022, Ms. FitzPatrick was also appointed as a member of the Compensation Committee. At March 31, 2025, Ms. FitzPatrick held options to purchase 32,434 registered shares of our common stock, of which options to purchase 27,147 shares were exercisable. | ||||
(5) | Ms. Cunningham served as an independent member of our Board and as a member of our Corporate Governance and Nominating Committee from January 2019 through April 30, 2021. On May 1, 2021, Ms. Cunningham joined the Company as its Chief Commercial Officer (CCO) and served in such capacity through November 11, 2022. During the period in which she served as CCO, her service on the Corporate Governance and Nominating Committee terminated. Ms. Cunningham re-joined the Corporate Governance and Nominating Committee from November 2022 until voluntarily stepping down from the position in September 2024. At March 31, 2025, Ms. Cunningham held options to purchase 51,603 registered shares of our common stock, of which options to purchase 45,900 shares were exercisable. | ||||
(6) | Dr. Curley was appointed to our Board in April 2021 and has also served as a member of our Corporate Governance and Nominating Committee since her appointment. At March 31, 2025, Dr. Curley held options to purchase 32,934 registered shares of our common stock, of which options to purchase 27,147 shares were exercisable. | ||||
(7) | Dr. Gin has served as a member of our Board and as a member of our Audit Committee since his appointment to the Board in 2016. Beginning in July 2021, he was also appointed as the chairperson of our Compensation Committee. At March 31, 2025, Dr. Gin beneficially held: (i) 13,334 shares of our common stock, which amount includes 6,667 shares held by Dr. Gin’s wife, and (ii) options to purchase 50,271 registered shares of our common stock, of which options to purchase 44,984 shares were exercisable. On June 23, 2025, Dr. Gin notified the Board of his intention to retire from the Board and all Board committee positions held at the end of his current term, which expires at the Annual Meeting. | ||||
(8) | Ms. Rotunno was appointed to our Board in July 2021 and, since her appointment to the Board, serves as a member of our Audit Committee and as chairperson of the Corporate Governance and Nominating Committee. At March 31, 2025, Ms. Rotunno held options to purchase 32,434 registered shares of our common stock, of which options to purchase 27,147 shares were exercisable. | ||||
(9) | Mr. Saxe currently serves as Chair of our Audit Committee and as a member of our Compensation Committee, and previously served as Chairman of our Board until October 2023. At March 31, 2025, Mr. Saxe held (i) 1,858 shares of our common stock and (ii) options to purchase 49,437 registered shares of our common stock, of which options to purchase 44,150 shares were exercisable. | ||||
Audit Committee | Compensation Committee | Corporate Governance and Nominating Committee | ||||||||||||||||||
| Margaret M. FitzPatrick, M.A. | Member | Member | ||||||||||||||||||
| Ann Cunningham, MBA | ||||||||||||||||||||
| Joanne Curley, Ph.D. | Member | |||||||||||||||||||
| Jerry B. Gin, Ph.D. | Member | Chair | ||||||||||||||||||
| Mary L. Rotunno, J.D. | Member | Chair | ||||||||||||||||||
| Jon S. Saxe, J.D., LL.M. | Chair | Member | ||||||||||||||||||
| ● | overseeing our accounting and financial reporting process; | |||||||
| ● | overseeing certain areas of risk for the Company, including our cybersecurity; | |||||||
| ● | selecting, retaining and replacing our independent auditors and evaluating their qualifications, independence and performance; | |||||||
| ● | reviewing and approving scope of the annual audit and audit fees; | |||||||
| ● | monitoring rotation of partners of independent auditors on engagement team as required by law; | |||||||
| ● | discussing with management and independent auditors the results of annual audit and review of quarterly financial statements; | |||||||
| ● | reviewing adequacy and effectiveness of internal control policies and procedures; | |||||||
| ● | approving retention of independent auditors to perform any proposed permissible non-audit services; | |||||||
| ● | overseeing internal audit functions and annually reviewing Audit Committee charter and committee performance; and | |||||||
| ● | preparing the Audit Committee report that the SEC requires in our annual proxy statement. | |||||||
| ● | reviewing and approving our compensation programs and arrangements applicable to our executive officers (as defined in Rule I 6a-I (f) of the Securities Exchange Act of 1934, as amended (the Exchange Act)), including all employment-related agreements or arrangements under which compensatory benefits are awarded or paid to, or earned or received by, our executive officers, including, without limitation, employment, severance, change of control and similar agreements or arrangements; | |||||||
| ● | determining the philosophy and objectives of our executive officer compensation programs; | |||||||
| ● | ensuring corporate performance measures and goals regarding executive officer compensation are set and determining the extent to which they are achieved, and any related compensation earned; | |||||||
| ● | establishing goals and objectives relevant to Chief Executive Officer compensation and determining Chief Executive Officer compensation based on the performance evaluation conducted by the Corporate Governance and Nominating Committee; | |||||||
| ● | with the assistance of our compensation consultant, ensure that our executive compensation programs are effective in attracting and retaining key employees and reinforcing business strategies and objectives for enhancing stockholder value, monitoring the administration of incentive-compensation plans and equity-based incentive plans as in effect and as adopted from time to time by the Board; | |||||||
| ● | reviewing and approving any new equity compensation plan or any material change to an existing plan; and | |||||||
| ● | reviewing and approving any stock option award or any other type of award as may be required for complying with any tax, securities, or other regulatory requirement, or otherwise determined to be appropriate or desirable by the Compensation Committee or Board. | |||||||
| ● | monitoring the size and composition of our Board; | |||||||
| ● | managing periodic assessments of our Board; | |||||||
| ● | making recommendations to our Board with respect to the nominations or elections of our directors; | |||||||
| ● | conducting an annual evaluation of our Chief Executive Officer in light of corporate performance measures and goals set by the Compensation Committee; | |||||||
| ● | reviewing the adequacy of our corporate governance policies and procedures and our Code of Business Conduct, and recommending any proposed changes to our Board for approval; and | |||||||
| ● | considering any requests for waivers from our Code of Business Conduct and ensure that we disclose such waivers as may be required by the exchange on which we are listed, if any, and rules and regulations of the SEC. | |||||||
| Name | Age | Position | ||||||||||||
| Shawn K. Singh, J.D. | 62 | President, Chief Executive Officer and Director | ||||||||||||
| Cynthia L. Anderson, CPA | 56 | Vice President and Chief Financial Officer | ||||||||||||
| Reid G. Adler, J.D. | 71 | Chief Legal Officer | ||||||||||||
| Elissa Cote | 50 | Chief Corporate Development Officer | ||||||||||||
| Joshua S. Prince, MBA | 54 | Chief Operating Officer | ||||||||||||
| ● | Shawn K. Singh, J.D., our President, Chief Executive Officer and member of our Board; | |||||||
| ● | Cynthia L. Anderson, CPA, our Chief Financial Officer and Treasurer; | |||||||
| ● | Reid G. Adler, J.D., our Chief Legal Officer; | |||||||
| ● | Joshua S. Prince, MBA, our Chief Operating Officer. | |||||||
| ● | advancement of the PALISADE-3 Phase 3 trial of fasedienol; | |||||||
| ● | initiation of the remaining key components of the Company’s U.S. registration-directed PALISADE Program, including initiating both the PALISADE-4 Phase 3 trial and the PALISADE repeat dose study, and other nonclinical studies for fasedienol; | |||||||
| ● | advancement of certain elements of the U.S. Investigational New Drug (IND)-enabling programs to facilitate additional potential Phase 2 development of itruvone for major depressive disorder and PH80 for vasomotor symptoms (hot flashes) due to menopause; and | |||||||
| ● | management of corporate expenses and other general and administrative goals. | |||||||
| Fiscal | Salary | Bonus(1) | Option Awards(2) | Total | |||||||||||||||||||||||||
| Name and Principal Position | Year | ($) | ($) | ($) | ($) | ||||||||||||||||||||||||
Shawn K. Singh, J.D. | 2025 | 650,000 | 276,250 | 1,551,432 | (3) | 2,477,682 | |||||||||||||||||||||||
| President, Chief Executive Officer and Director | 2024 | 622,917 | 325,000 | - | 947,917 | ||||||||||||||||||||||||
Cynthia L. Anderson, CPA | 2025 | 443,750 | 198,450 | 465,256 | (3) | 1,107,456 | |||||||||||||||||||||||
| Chief Financial Officer and Treasurer | 2024 | 261,198 | (4) | 130,000 | 42,993 | (5) | 434,191 | ||||||||||||||||||||||
| Reid G. Adler, J.D. | 2025 | 450,000 | 198,450 | 527,357 | (3) | 1,175,807 | |||||||||||||||||||||||
| Chief Legal Officer | 2024 | 450,000 | 225,000 | - | 675,000 | ||||||||||||||||||||||||
Joshua S. Prince, MBA | 2025 | 410,000 | 183,015 | 465,235 | (3) | 1,058,250 | |||||||||||||||||||||||
| Chief Operating Officer | 2024 | (6) | 368,437 | 200,000 | - | 568,437 | |||||||||||||||||||||||
(1) | Amounts reported in the Bonus column for Fiscal 2025 and Fiscal 2024 reflect bonuses awarded by the Compensation Committee that were earned in the same period. | ||||
(2) | The amounts shown in the “Option Awards” column do not represent any cash payments actually received by any NEO during Fiscal 2025. Rather, the amounts shown represent the aggregate grant date fair value of options to purchase shares of our common stock awarded to the NEOs during the fiscal year presented, computed in accordance with the Financial Accounting Standards Board’s Accounting Standards Codification Topic 718, Compensation – Stock Compensation (ASC 718). | ||||
(3) | The following below provides information regarding the stock option awards granted to our NEOs in Fiscal 2025 and the assumptions used in the Black Scholes Option Pricing Model to determine the grant date fair values of the respective awards. | ||||
| Option Award Compensation | Option Grant | |||||||||||||
| Fiscal Year Ended March 31, 2025 | 6/24/2024 | |||||||||||||
| Mr. Singh | 500,000 | |||||||||||||
| Ms. Anderson | 150,000 | |||||||||||||
| Mr. Adler | 170,000 | |||||||||||||
| Mr. Prince | 150,000 | |||||||||||||
| Option Award Compensation | Option Grant | |||||||||||||
| Fiscal Year Ended March 31, 2025 | 6/24/2024 | |||||||||||||
| Mr. Singh | $ | 1,551,432 | ||||||||||||
| Ms. Anderson | $ | 465,256 | ||||||||||||
| Mr. Adler | $ | 527,357 | ||||||||||||
| Mr. Prince | $ | 465,235 | ||||||||||||
Option Award Assumptions – | Option Grant | |||||||||||||
| Fiscal Year Ended March 31, 2025 | 6/24/2024 | |||||||||||||
| Market price per share | $ | 3.25 | ||||||||||||
| Exercise price per share | $ | 3.25 | ||||||||||||
| Risk-free interest rate | 4.22 | % | ||||||||||||
| Volatility | 167.17 | % | ||||||||||||
| Expected term (years) | 5.77 | |||||||||||||
| Dividend rate | 0.0 | % | ||||||||||||
| Fair value per share | $ | 3.10 | ||||||||||||
| Aggregate shares | 970,000 | |||||||||||||
(4) | Ms. Anderson was appointed as the Company’s Chief Financial Officer in August 2023. As such, base salary paid to Ms. Anderson is for services rendered during a portion of Fiscal 2024. | ||||
(5) | Ms. Anderson received a grant of options to purchase 8,333 registered shares of our common stock upon commencement of her employment by the Company in August 2023. The table below provides information regarding the stock option granted to Ms. Anderson upon commencement of her employment by the Company during Fiscal 2024 and the assumptions used in the Black Scholes Option Pricing Model to determine the grant date fair value of her new-hire award. | ||||
| Option Award Compensation | Option Grant | |||||||||||||
| Fiscal Year Ended March 31, 2024 | 8/21/2023 | |||||||||||||
| Ms. Anderson | $ | 42,993 | ||||||||||||
Option Award Assumptions – | Option Grant | |||||||||||||
| Fiscal Year Ended March 31, 2024 | 8/21/2023 | |||||||||||||
| Market price per share | $ | 5.34 | ||||||||||||
| Exercise price per share | $ | 5.34 | ||||||||||||
| Risk-free interest rate | 4.39 | % | ||||||||||||
| Volatility | 167.68 | % | ||||||||||||
| Expected term (years) | 6.08 | |||||||||||||
| Dividend rate | 0.0 | % | ||||||||||||
| Fair value per share | $ | 5.1594 | ||||||||||||
| Aggregate shares | 8,333 | |||||||||||||
(6) | Mr. Prince was appointed as the Company’s Chief Operating Officer in October 2023. Prior to this appointment, Mr. Prince served as the Company’s Senior Vice President, Business Operations. | ||||
| ● | A participant cannot contribute less than 1% or more than 15% of his or her compensation to the purchase of stock under the 2019 ESPP in any one payroll period; | |||||||
| ● | A participant cannot accrue rights to purchase more than a maximum of $25,000 of common stock (valued at the grant date of the applicable offering period and without giving effect to any discount reflected in the purchase price for the stock) for each calendar year in which an option is outstanding; and | |||||||
| ● | A participant will not be granted an option under the 2019 ESPP if it would cause the participant to own common stock and/or hold outstanding options to purchase common stock constituting 5.0% or more of the total combined voting power or value of all classes of stock of the Company or of one of its subsidiaries or to the extent it would exceed certain other limits under the Code. | |||||||
| Semi-Annual Purchase Period Ended | ||||||||||||||||||||||||||||||||||||||
June 30, 2023 | December 31, 2023 | June 30, 2024 | December 31, 2024 | |||||||||||||||||||||||||||||||||||
| Per share purchase price | $ | 1.59 | $ | 4.37 | $ | 2.958 | $ | 2.5075 | ||||||||||||||||||||||||||||||
Shares purchased by: | ||||||||||||||||||||||||||||||||||||||
Mr. Singh(1) | 167 | 167 | 4,854 | - | ||||||||||||||||||||||||||||||||||
Ms. Anderson (2) | - | - | 3,592 | 2,592 | ||||||||||||||||||||||||||||||||||
Mr. Adler (1) | 167 | 167 | 4,854 | - | ||||||||||||||||||||||||||||||||||
| Mr. Prince | - | - | 2,671 | 3,310 | ||||||||||||||||||||||||||||||||||
(1) | Both Mr. Singh and Mr. Adler met the annual purchase limit of $25,000 under the Code with their respective purchases for the June 30, 2024 purchase period. As such, pursuant to the Code, they were not eligible to make any additional purchases during the December 31, 2024 purchase period. | ||||
(2) | Ms. Anderson joined the Company in August 2023, and, as such, was not eligible to participate in the 2019 ESPP until the purchase option period ending June 30, 2024. | ||||
| Stock Options at March 31, 2025 | ||||||||||||||||||||||||||||||||
| Name | Number of Securities Underlying Unexercised Options (#) Exercisable | Number of Securities Underlying Unexercised Options (#) Unexercisable | Exercise Price ($) | Expiration Date | ||||||||||||||||||||||||||||
| Shawn K. Singh, J.D. | 6,667 | — | $ | 45.00 | 6/19/2026 | |||||||||||||||||||||||||||
| 3,334 | — | $ | 45.00 | 11/9/2026 | ||||||||||||||||||||||||||||
| 5,834 | — | $ | 45.00 | 4/26/2027 | ||||||||||||||||||||||||||||
| 4,167 | — | $ | 46.80 | 9/19/2027 | ||||||||||||||||||||||||||||
| 10,000 | — | $ | 34.80 | 2/2/2028 | ||||||||||||||||||||||||||||
| 7,334 | — | $ | 51.00 | 1/14/2029 | ||||||||||||||||||||||||||||
| 2,667 | — | $ | 30.00 | 5/23/2029 | ||||||||||||||||||||||||||||
| 2,334 | — | $ | 30.00 | 9/5/2029 | ||||||||||||||||||||||||||||
| 10,001 | — | $ | 42.30 | 10/21/2029 | ||||||||||||||||||||||||||||
| 10,001 | — | $ | 11.94 | 4/23/2030 | ||||||||||||||||||||||||||||
| 10,001 | — | $ | 53.10 | 12/30/2030 | ||||||||||||||||||||||||||||
| 10,001 | — | $ | 41.10 | 3/1/2032 | ||||||||||||||||||||||||||||
| 125,000 | 375,000 | (1) | $ | 3.23 | 6/24/2034 | |||||||||||||||||||||||||||
| Total: | 207,341 | 375,000 | ||||||||||||||||||||||||||||||
| Cynthia L. Anderson, CPA | 3,298 | 5,035 | (2) | $ | 5.34 | 8/21/2033 | ||||||||||||||||||||||||||
| 37,500 | 112,500 | (3) | $ | 3.23 | 6/24/2024 | |||||||||||||||||||||||||||
| Total: | 40,798 | 117,535 | ||||||||||||||||||||||||||||||
Reid G. Adler, J.D.(2) | 1,667 | — | $ | 46.80 | 9/19/2027 | |||||||||||||||||||||||||||
| 834 | — | $ | 34.80 | 2/2/2028 | ||||||||||||||||||||||||||||
| 667 | — | $ | 30.00 | 5/23/2029 | ||||||||||||||||||||||||||||
| 834 | — | $ | 42.30 | 10/21/2029 | ||||||||||||||||||||||||||||
| 834 | — | $ | 11.94 | 4/23/2030 | ||||||||||||||||||||||||||||
| 1,667 | — | $ | 82.20 | 7/16/2031 | ||||||||||||||||||||||||||||
| 1,667 | — | $ | 41.10 | 3/1/2032 | ||||||||||||||||||||||||||||
| 4,724 | 1,943 | (5) | $ | 38.40 | 5/2/2032 | |||||||||||||||||||||||||||
| 42,500 | 127,500 | (6) | $ | 3.23 | 6/24/2024 | |||||||||||||||||||||||||||
| Total: | 55,394 | 129,443 | ||||||||||||||||||||||||||||||
| Joshua S. Prince, MBA | 2,920 | 2,080 | (7) | $ | 64.50 | 11/15/2031 | ||||||||||||||||||||||||||
| 3,334 | — | $ | 41.10 | 3/1/2032 | ||||||||||||||||||||||||||||
| 1,670 | 3,331 | (8) | $ | 4.44 | 11/16/2032 | |||||||||||||||||||||||||||
| 37,500 | 112,500 | (9) | $ | 3.23 | 6/24/2024 | |||||||||||||||||||||||||||
| Total: | 47,923 | 115,412 | ||||||||||||||||||||||||||||||
(1) | Represents an option to purchase 500,000 shares of our common stock at $3.23 per share granted on June 24, 2024 when the market price of our common stock was $3.23 per share. The option will vest in equal monthly installments over a three-year period and become fully vested on June 24, 2027, when all shares granted will be fully exercisable. | ||||
(2) | Represents an option to purchase shares of our common stock at $5.34 per share granted on August 21, 2023 when the market price of our common stock was $5.34 per share. The option will become exercisable for 25% of the shares granted on the first anniversary of the grant date, with the remaining 75% of the shares becoming exercisable ratably monthly through August 21, 2027, when all shares granted will be fully exercisable. | ||||
(3) | Represents an option to purchase 150,000 shares of our common stock at $3.23 per share granted on June 24, 2024 when the market price of our common stock was $3.23 per share. The option will vest in equal monthly installments over a three-year period and become fully vested on June 24, 2027, when all shares granted will be fully exercisable. | ||||
(4) | All options held by Mr. Adler to purchase shares of our common stock reflected in this table as expiring on or before March 1, 2032 were awarded to him for services to the Company as a legal advisor prior to his employment by the Company effective May 2, 2022. | ||||
(5) | Represents an option to purchase 6,667 shares of our common stock at $38.40 per share granted to Mr. Adler upon commencement of his employment by the Company on May 2, 2022 when the market price of our common stock was $38.40 per share. The option became exercisable for 25% of the shares granted on the first anniversary of the grant date, with the remaining 75% of the shares becoming exercisable ratably monthly through May 2, 2026, when all shares granted will be fully exercisable. | ||||
(6) | Represents an option to purchase 170,000 shares of our common stock at $3.23 per share granted on June 24, 2024 when the market price of our common stock was $3.23 per share. The option will vest in equal monthly installments over a three-year period and become fully vested on June 24, 2027, when all shares granted will be fully exercisable. | ||||
(7) | Represents an option to purchase shares of our common stock at $64.50 per share granted on November 15, 2021 when the market price of our common stock was $64.50 per share. The option will become exercisable for 25% of the shares granted on the first anniversary of the grant date, with the remaining 75% of the shares becoming exercisable ratably monthly through November 15, 2025, when all shares granted will be fully exercisable. | ||||
(8) | Represents an option to purchase 150,000 shares of our common stock at $3.23 per share granted on June 24, 2024 when the market price of our common stock was $3.23 per share. The option will vest in equal monthly installments over a three-year period and become fully vested on June 24, 2027, when all shares granted will be fully exercisable. | ||||
(9) | Represents an option to purchase shares of our common stock at $4.437 per share granted on November 16, 2022 when the market price of our common stock was $4.437 per share. The option will become exercisable for 25% of the shares granted on the first anniversary of the grant date, with the remaining 75% of the shares becoming exercisable ratably monthly through November 16, 2026, when all shares granted will be fully exercisable. | ||||
| ● | twelve months of his then-current base salary payable in the form of salary continuation; | |||||||
| ● | a pro-rated portion of the incentive cash bonus that the Board of Directors determines in good faith that Mr. Singh earned prior to such termination; and | |||||||
| ● | such amounts required to reimburse him for Consolidated Omnibus Budget Reconciliation Act (COBRA) payments for continuation of his medical health benefits for a twelve-month period from such termination. | |||||||
| ● | a material reduction in his responsibility; or | |||||||
| ● | a material reduction in his base salary except for reductions that are comparable to reductions generally applicable to similarly situated executives the Company. | |||||||
| Year | Summary Compensation Table Total for PEO(1) | Compensation Actually Paid to PEO(2) | Average Summary Compensation Total for Non- PEO Named Executive Officers(3) | Average Compensation Actually Paid to Non-PEO Named Executive Officers(4) | Value of Initial $100 Investment based on Total Stockholder Return(5) | Net Income (Loss) Attributable to Common Stockholders ($) | ||||||||||||||||||||||||||||||||
| Fiscal 2025 | $ | 2,477,682 | $ | $ | 1,113,838 | $ | $ | 7.25 | $ | ( | ||||||||||||||||||||||||||||
| Fiscal 2024 | $ | $ | $ | $ | $ | $ | ( | |||||||||||||||||||||||||||||||
| Fiscal 2023 | $ | $ | $ | $ | $ | $ | ( | |||||||||||||||||||||||||||||||
(1) | |||||
(2) | The following amounts were added to and deducted from the Summary Compensation Table (SCT) amount to determine the compensation actually paid to the PEO as determined in accordance with SEC regulations: | ||||
Adjustments to Determine Compensation “Actually Paid” | Fiscal 2025 | Fiscal 2024 | Fiscal 2023 | |||||||||||||||||
| Deduction for amount reported under the “Stock Awards” column in the SCT | $ | $ | $ | |||||||||||||||||
| Deduction for amount reported under the “Option Awards” column in the SCT | ( | |||||||||||||||||||
| Increase for the fair value of awards granted during year that remain unvested as of year-end | ||||||||||||||||||||
| Increase for the fair value of awards granted during year that remain vested as of year-end | ||||||||||||||||||||
| Increase/deduction for change in fair value from prior year-end to current year-end of awards granted prior to year-end that were outstanding and unvested as of year-end | ( | |||||||||||||||||||
| Increase/deduction for change in fair value from prior year-end to vesting date of awards granted prior to year-end that vested during year | ( | ( | ||||||||||||||||||
| Deduction of fair value of awards granted prior to year-end that were forfeited during year | ||||||||||||||||||||
| Increase based upon incremental fair value of awards modified during year | ||||||||||||||||||||
| Increase based on dividends or other earnings paid during year prior to vesting date of award. | ||||||||||||||||||||
| Total Adjustments | $ | ( | $ | $ | ( | |||||||||||||||
(3) | For Fiscal 2025 and Fiscal 2024, our other NEOs consisted of Cynthia L. Anderson, Reid G. Adler and Joshua S. Prince. For Fiscal 2023, our other NEOs consisted of Jerrold D. Dotson, CPA, our former Chief Financial Officer, and Mr. Adler. | ||||
(4) | For our other NEOs, the following amounts were added and deducted to the SCT amount to determine the average compensation “actually paid” as determined in accordance with SEC regulations. | ||||
Adjustments to Determine Compensation “Actually Paid” | Fiscal 2025 | Fiscal 2024 | Fiscal 2023 | |||||||||||||||||||||||
| Deduction for amount reported under the “Stock Awards” column in the SCT | $ | $ | $ | |||||||||||||||||||||||
| Deduction for amount reported under the “Option Awards” column in the SCT | ( | ( | ( | |||||||||||||||||||||||
| Increase for the fair value of awards granted during year that remain unvested as of year-end | ||||||||||||||||||||||||||
| Increase for the fair value of awards granted during year that remain vested as of year-end | ||||||||||||||||||||||||||
| Increase/deduction for change in fair value from prior year-end to current year-end of awards granted prior to year-end that were outstanding and unvested as of year-end | ( | ( | ||||||||||||||||||||||||
| Increase/deduction for change in fair value from prior year-end to vesting date of awards granted prior to year-end that vested during year | ( | ( | ||||||||||||||||||||||||
| Deduction of fair value of awards granted prior to year-end that were forfeited during year | ||||||||||||||||||||||||||
| Increase based upon incremental fair value of awards modified during year | ||||||||||||||||||||||||||
| Increase based on dividends or other earnings paid during year prior to vesting date of award. | ||||||||||||||||||||||||||
| Total Adjustments | $ | ( | $ | $ | ( | |||||||||||||||||||||
| Fair values used in the determination of CAP are determined using the same methodology as used for determining grant date fair values in our financial statements. Specifically, the fair value of option awards was calculated in accordance with the Financial Accounting Standards Board’s Accounting Standards Codification Topic 718, Compensation - Stock Compensation, and does not reflect any amounts actually paid to or actually realized by Messrs. Dotson or Adler. The fair value of the option awards used in the determination of CAP was estimated using the Black-Scholes option pricing model and valuation assumptions reflecting the closing price of our common stock and related assumptions on the respective valuation dates. The grant date valuation assumptions used in the valuation of option awards may be found in the applicable footnotes to the SCT on page 26 above. | |||||
(5) | Assumes $100 invested in our common stock on March 31, 2022, and calculated based on the difference between the closing price of our common stock, as reported on The Nasdaq Capital Market, on March 31, 2025, March 31, 2024 and 2023, the end and beginning of the measurement period, respectively, and adjusted to give effect to the Reverse Split completed in June 2023. | ||||
Fiscal Years Ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Audit fees | $ | 575,000 | $ | 542,000 | |||||||
| Audit-related fees | — | — | |||||||||
| Tax fees | — | 24,000 | |||||||||
| All other fees | — | — | |||||||||
| Total fees | $ | 575,000 | $ | 566,000 | |||||||
Respectfully Submitted by: MEMBERS OF THE AUDIT COMMITTEE Jon S. Saxe, Audit Committee Chair Jerry B. Gin* Mary L. Rotunno | |||||
| Dated: June 9, 2025 | |||||
| * | Dr. Gin notified the Board of his intention to retire from the Board and all Board committee positions held at the end of his current term, which term expires at the Annual Meeting. | ||||
| ● | each of our NEOs; | |||||||
| ● | each of our directors; | |||||||
| ● | all of our directors and NEOs as a group; and | |||||||
| ● | our 5%+ stockholders. | |||||||
| Name and address of beneficial owner | Number of shares beneficially owned | Percent of shares beneficially owned(1) | ||||||||||||||||||||||||
| Named Executive Officers: | ||||||||||||||||||||||||||
Shawn K. Singh, J.D. (2) President, Chief Executive Officer and Director | 332,355 | 1.10 | % | |||||||||||||||||||||||
Cynthia L. Anderson, CPA (3) Chief Financial Officer | 80,856 | * | ||||||||||||||||||||||||
Reid G. Adler, J.D. (4) Chief Legal Officer | 109,445 | * | ||||||||||||||||||||||||
Joshua S. Prince, MBA (5) Chief Operating Officer | 86,215 | * | ||||||||||||||||||||||||
| Non-Employee Directors: | * | |||||||||||||||||||||||||
Margaret M. FitzPatrick, M.A. (6) Board Chair | 32,434 | * | ||||||||||||||||||||||||
Ann M. Cunningham, MBA (7) Director | 51,603 | * | ||||||||||||||||||||||||
Joanne Curley, Ph.D. (8) Director | 32,434 | * | ||||||||||||||||||||||||
Jerry B. Gin, Ph.D., MBA (9) Director | 63,605 | * | ||||||||||||||||||||||||
Mary L. Rotunno, J.D. (10) Director | 32,434 | * | ||||||||||||||||||||||||
Jon S. Saxe, J.D., LL.M. (11) Director | 51,295 | * | ||||||||||||||||||||||||
All executive officers and directors as a group (11 persons) (12) | 872,676 | 2.85 | % | |||||||||||||||||||||||
5%+ Stockholders: | ||||||||||||||||||||||||||
Commodore Capital Master Fund LP (13) 444 Madison Ave., Floor 35 New York, New York 10022 | 7,447,944 | 20.84 | % | |||||||||||||||||||||||
TCG Crossover Fund II, L.P. (14) 705 High St. Palo Alto, California 94301 | 5,636,983 | 13.18 | % | |||||||||||||||||||||||
Nantahala Capital Management, LLC (15) 130 Main St., 2nd Floor New Canaan, Connecticut 06840 | 3,545,423 | 11.32 | % | |||||||||||||||||||||||
StemPoint Capital Master Fund LP (16) 520 Madison, Ave., 19th Floor New York, New York 10022 | 3,293,329 | 10.81 | % | |||||||||||||||||||||||
Entities affiliated with BVF, Inc. (17) 44 Montgomery St. San Francisco, California 94104 | 3,037,835 | 9.23 | % | |||||||||||||||||||||||
The Vanguard Group (18) 100 Vanguard Blvd. Malvern, Pennsylvania 19355 | 1,976,172 | 6.62 | % | |||||||||||||||||||||||
Great Point Partners, LLC (19) 165 Mason St., 3rd Floor Greenwich, Connecticut | 2,055,834 | 6.44 | % | |||||||||||||||||||||||
| * | less than 1% | ||||
(1) | Based on 29,859,961 shares of common stock outstanding as of July 16, 2025. Percentages reported herein do not give effect to beneficial ownership blockers contained within outstanding common stock purchase warrants. | ||||
(2) | Number of shares beneficially held consists of (i) 38,903 shares of common stock, of which 20,875 shares of common stock are held by The 1997 Singh Family Trust, and (ii) stock options to purchase up to 293,452 shares of registered common stock exercisable within 60 days of July 16, 2025. | ||||
(3) | Number of shares beneficially held consists of (i) 12,801 shares of common stock, and (ii) stock options to purchase up to 68,055 shares of registered common stock exercisable within 60 days of July 16, 2025. | ||||
(4) | Number of shares beneficially held consists of (i) 24,050 shares of common stock, and (ii) stock options to purchase up to 85,395 shares of registered common stock exercisable within 60 days of July 16, 2025. | ||||
(5) | Number of shares beneficially held consists of of (i) 10,863 shares of common stock, and (ii) stock options to purchase up to 75,352 shares of registered common stock exercisable within 60 days of July 16, 2025. | ||||
(6) | Number of shares beneficially held consists of stock options to purchase up to 32,434 shares of registered common stock exercisable within 60 days of July 16, 2025. | ||||
(7) | Number of shares beneficially held consists of stock options to purchase up to 51,603 shares of registered common stock exercisable within 60 days of July 16, 2025. | ||||
(8) | Number of shares beneficially held consists of stock options to purchase up to 32,434 shares of registered common stock exercisable within 60 days of July 16, 2025. | ||||
(9) | Number of shares beneficially held consists of (i) 13,334 shares of common stock, of which 667 shares are held by Dr. Gin’s wife, and (ii) stock options to purchase up to 50,271 shares of registered common stock exercisable within 60 days of July 16, 2025. As previously noted, on June 23, 2025, Dr. Gin notified the Board of his intention to retire from the Board and all Board committee positions held at the end of his current term, which expires at the Annual Meeting. | ||||
(10) | Number of shares beneficially held consists of stock options to purchase up to 32,434 shares of registered common stock exercisable within 60 days of July 16, 2025. | ||||
(11) | Number of shares beneficially held consists of (i) 1,858 shares of common stock, and (ii) stock options to purchase up to 49,437 shares of registered common stock exercisable within 60 days of July 16, 2025. | ||||
(12) | Number of shares beneficially held consists of an aggregate of (i) 101,809 shares of common stock, and (ii) stock options to purchase up to 770,867 shares of registered common stock exercisable within 60 days of July 16, 2025. | ||||
(13) | Reported holdings based upon Amendment No. 1 to Schedule 13G filed by Commodore Capital LP (Commodore) on October 6, 2023 and Company records. Number of shares beneficially held consists of (i) 1,575,000 shares of common stock and (ii) up to 5,872,944 shares of common stock issuable upon exercise of certain warrants beneficially held by Commodore. Commodore is the investment manager to Commodore Capital Master LP (Commodore Master) and Messrs. Michael Kramarz and Robert Egen are the managing partners of Commodore. As such, Commodore, Mr. Kramarz and Mr. Egen may be deemed to beneficially own the shares beneficially held by Commodore Master. | ||||
(14) | Reported holdings based upon Schedule 13G filed by TCG Crossover GP II, LLC (TCG Crossover) on October 16, 2023 and Company records. Number of shares beneficially held consists of (i) 2,007,435 shares of common stock and (ii) up to 2,220,302 shares of common stock issuable upon exercise of certain warrants beneficially held by TCG Crossover. TCG Crossover is the General Partner of TCG Crossover Fund II, L.P. and Dr. Chen Yu is the Managing Member of TCG Crossover. As such, TCG Crossover and Dr. Yu may be deemed to beneficially own the shares beneficially held by TCG Crossover. | ||||
(15) | Reported holdings based upon Amendment No. 1 to Schedule 13G filed by Nantahala Capital Management, LLC (Nantahala) on November 14, 2024 and Company records. Number of shares beneficially held consists of (i) 2,095,492 shares of common stock and (ii) up to 1,449,931 shares of common stock issuable upon exercise of certain warrants beneficially held by Nantahala and Blackwell Partners LLC-Series A, a fund advised by Nantahala. Messrs. Wilmot B. Harkey and Daniel Mack are the managing members of Nantahala and, as such, may be deemed to beneficially own the shares beneficially held by Nantahala. | ||||
(16) | Reported holdings based upon Amendment No. 1 Schedule 13G filed by StemPoint Capital LP (StemPoint) on February 14, 2025 and Company records. Number of shares beneficially held consists of (i) 2,676,580 shares of common stock and (ii) up to 616,749 shares of common stock issuable upon exercise of certain warrants beneficially held by StemPoint. StemPoint Capital Management GP LLC (StemPoint GP) is the General Partner of StemPoint and Ms. Michelle Ross is the Managing Partner of StemPoint GP. As such, StemPoint GP and Ms. Ross may be deemed to beneficially own the shares beneficially held by StemPoint. | ||||
(17) | Reported holdings based upon Amendment No. 1 to Schedule 13G filed by Biotechnology Value Fund L.P. (BVF) on February 14, 2025. Number of shares beneficially held consists of up to 3,084,324 shares of common stock issuable upon exercise of certain warrants beneficially held by BVF, Inc. and its affiliates. Entities affiliated with BVF, Inc. consist of BVF, BVF I GP LLC (BVF GP), Biotechnology Value Fund II, L.P. (BVF2), BVF II GP LLC (BVF2 GP), Biotechnology Value Trading Fund OS LP (Trading Fund OS), BVF Partners OS Ltd. (Partners OS), BVF GP Holdings LLC (BVF GPH) and BVF Partners L.P. (Partners). BVF GP is the general partner of BVF and may be deemed to beneficially own the shares held by BVF. BVF2 GP is the general partner of BVF2 and may be deemed to beneficially own the shares held by BVF2. Partners OS is the general partner of Trading Fund OS and may be deemed to beneficially own the shares held by Trading Fund OS. BVF GPH is the sole member of each of BVF GP and BVF2 GP, and may be deemed to beneficially own in the aggregate the shares held by BVF and BVF2. Partners is the investment manager of BVF, BVF2 and Trading Fund OS, and is the sole member of Partners OS and may be deemed to beneficially own in the aggregate shares held by BVF, BVF2 and Trading Fund OS. BVF, Inc. is the general partner of Partners and may be deemed to beneficially own the shares held by Partners. Mr. Mark N. Lampert is a director and officer of BVF, Inc and may be deemed to beneficially own the shares held by BVF, Inc. | ||||
(18) | Reported holdings based upon Schedule 13G filed by The Vanguard Group (Vanguard) on February 13, 2024 and Company records. | ||||
(19) | Reported holdings based upon Amendment No. 4 to Schedule 13G filed by Great Point Partners, LLC (Great Point) on May 15, 2025. Number of shares beneficially held consists of up to 2,055,834 shares of common stock issuable upon exercise of certain warrants beneficially held by Great Point. Jeffrey R. Jay, M.D. is the Senior Managing Director of Great Point and Ms. Lillian Nordahl is the Managing Director of Great Point. As such, Dr. Jay and Ms. Nordhahl may be deemed to beneficially own the shares beneficially held by Great Point. | ||||
| Plan category | Number of securities to be issued upon exercise of outstanding options, warrants and rights (a) | Weighted- average exercise price of outstanding options, warrants and rights (b) | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a) (c) | |||||||||||||||||
| Equity compensation plans approved by security holders | ||||||||||||||||||||
| 2019 Plan and 2016 Plan | 3,239,642 | $ | 10.32 | 2,042,153 | ||||||||||||||||
| 2019 ESPP | - | - | 911,342 | |||||||||||||||||
| Equity compensation plans not approved by security holders | - | - | - | |||||||||||||||||
| Total | 3,239,642 | 2,953,495 | ||||||||||||||||||
| Awards and Eligible Participants | The 2019 Plan is designed to secure and retain the services of our employees, non-employee directors and consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and our affiliates, and to provide a means by which such persons may be given an opportunity to benefit from increases in the value of our common stock. The 2019 Plan is also designed to align employees’ interests with stockholder interests. The 2019 Plan provides for the grant of stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, and other stock-based awards, and performance awards, collectively referred to as “Awards”. Awards may be granted under the 2019 Plan to officers, employees and consultants of the Company and our subsidiaries and to our non-employee directors. Incentive stock options may be granted only to employees of the Company or one of our subsidiaries. | |||||||
| Plan Administration | The 2019 Plan is administered by the Compensation Committee of the Board. The Compensation Committee, in its discretion, selects the individuals to whom awards may be granted, the time or times at which such awards are granted, and the terms of such awards. The Compensation Committee may delegate its authority to the extent permitted by applicable law. The Compensation Committee sets stock option exercise prices and terms, except that stock options must be granted with an exercise price not less than 100% of the fair market value of the common stock on the date of grant. The Compensation Committee may grant either incentive stock options, which must comply with Section 422 of the Code, or nonqualified stock options. At the time of grant, the Compensation Committee determines the terms and conditions of stock options, including the quantity, exercise price, vesting periods, term (which cannot exceed ten years) and other conditions on exercise. The Compensation Committee may grant SARs as a right in tandem with the number of shares underlying stock options granted under the 2019 Plan or as a freestanding award. Upon exercise, SARs entitle the holder to receive payment per share in stock or cash, or in a combination of stock and cash, equal to the excess of the share’s fair market value on the date of exercise over the grant price of the SAR. The Compensation Committee may also grant awards of restricted stock, which are shares of common stock subject to specified restrictions, and restricted stock units, which represent the right to receive shares of common stock in the future. These awards may be made subject to repurchase, forfeiture or vesting restrictions at the Compensation Committee’s discretion. The restrictions may be based on continuous service with the Company or the attainment of specified performance goals, as determined by the Compensation Committee. Stock units may be paid in stock or cash or a combination of stock and cash, as determined by the Compensation Committee. The Compensation Committee may condition the grant, exercise, vesting, or settlement of any award on such performance conditions as it may specify. We refer to these awards as “performance awards.” The Compensation Committee may select such business criteria or other performance measures as it may deem appropriate in establishing any performance conditions. At March 31, 2025, the Compensation Committee has not granted any performance awards. | |||||||
| Authorized Shares | As of the date of this Proxy Statement, a total of 5.0 million shares of common stock is authorized for issuance under the 2019 Plan. In the event any award under the 2019 Plan is canceled, terminates, expires or lapses for any reason prior to the issuance of shares or if shares are issued under the 2019 Plan and thereafter are forfeited to us, the shares subject to such awards and the forfeited shares will again be available for grant under the 2019 Plan. | |||||||
| Vesting | No more than 25% of any equity-based awards granted under the 2019 Plan may vest on the grant date of such award. The Board believes this provision provides the Company the necessary flexibility to issue Awards that will both attract new talent, particularly as the Company advances its late-stage clinical development and commercialization plans for its drug candidates and provide incentives sufficient to retain the Company’s existing employees and directors. This requirement does not apply to (i) substitute awards resulting from acquisitions or (ii) shares delivered in lieu of fully vested cash awards. In addition, the minimum vesting requirement does not apply to the Compensation Committee’s discretion to provide for accelerated exercisability or vesting of any award, including in cases of retirement, death, disability or a change in control, in the terms of the award or otherwise. Awards are not transferable other than by will or the laws of descent and distribution, except that in certain instances transfers may be made to or for the benefit of designated family members of the participant for no consideration. | |||||||
| ● | A participant cannot contribute less than 1% or more than 15% of his or her compensation to the purchase of stock under the 2019 ESPP in any one payroll period; | |||||||
| ● | A participant cannot accrue rights to purchase more than $25,000 of common stock (valued at the grant date of the applicable offering period and without giving effect to any discount reflected in the purchase price for the stock) for each calendar year in which an option is outstanding; and | |||||||
| ● | A participant will not be granted an option under the 2019 ESPP if it would cause the participant to own common stock and/or hold outstanding options to purchase common stock constituting 5.0% or more of the total combined voting power or value of all classes of stock of the Company or of one of its subsidiaries or to the extent it would exceed certain other limits under the Code. | |||||||
Cover |
12 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Document Information [Line Items] | |
| Document Type | DEF 14A |
| Amendment Flag | false |
| Entity Information [Line Items] | |
| Entity Registrant Name | VISTAGEN THERAPEUTICS, INC. |
| Entity Central Index Key | 0001411685 |
Pay vs Performance Disclosure - USD ($) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Mar. 31, 2023 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure, Table |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Named Executive Officers, Footnote |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PEO Total Compensation Amount | $ 947,917 | $ 600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PEO Actually Paid Compensation Amount | $ 2,063,866 | 1,175,054 | 225,350 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment To PEO Compensation, Footnote |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-PEO NEO Average Total Compensation Amount | 559,209 | 493,409 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-PEO NEO Average Compensation Actually Paid Amount | $ 982,081 | 575,433 | 304,160 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Non-PEO NEO Compensation Footnote |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Compensation Actually Paid vs. Total Shareholder Return | Compensation Actually Paid and Total Stockholder Return |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Compensation Actually Paid vs. Net Income | Compensation Actually Paid and Net Loss |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Shareholder Return Amount | 8.42 | 5.85 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Income (Loss) | $ (51,418,000) | (29,362,000) | (59,247,700) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PEO Name | Shawn K. Singh, J.D. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Additional 402(v) Disclosure |
We generally seek to incentivize a mix between current and long-term performance and therefore do not specifically align our performance measures with “compensation actually paid” (as computed in accordance with Item 402(v) of Regulation S-K) for a particular year. In accordance with Item 402(v) of Regulation S-K, we are providing the following descriptions of the relationships between the information presented in the Pay Versus Performance table. The disclosure included in this section is prescribed by SEC rules and does not necessarily align with how the Company or the Compensation Committee views the relationship between the Company’s performance and the compensation of our NEOs.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PEO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | $ (413,817) | 227,137 | (374,650) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | 865,150 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | 0 | 222,115 | (87,164) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | 288,223 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | (15,758) | 5,022 | (287,486) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PEO | Aggregate Grant Date Fair Value of Stock Award Amounts Reported in Summary Compensation Table [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PEO | Aggregate Grant Date Fair Value of Option Award Amounts Reported in Summary Compensation Table [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | (1,551,432) | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year Modified During Covered Year [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-PEO NEO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | (131,756) | 16,224 | (189,249) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | 275,840 | 14,331 | 4,306 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | (6,885) | 7,945 | (19,664) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | 91,798 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | (6,560) | 8,279 | (83,607) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-PEO NEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-PEO NEO | Aggregate Grant Date Fair Value of Stock Award Amounts Reported in Summary Compensation Table [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-PEO NEO | Aggregate Grant Date Fair Value of Option Award Amounts Reported in Summary Compensation Table [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | (485,949) | (14,331) | (90,284) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year Modified During Covered Year [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pay vs Performance Disclosure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment to Compensation, Amount | $ 0 | $ 0 | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Award Timing Disclosure |
12 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Award Timing Disclosures [Line Items] | |
| Award Timing MNPI Disclosure | Option grants to employees, executive officers and non-employee directors are made by the Compensation Committee under the 2019 Plan from time to time, as determined by the Compensation Committee. We do not have any formal policy that requires the Company to grant, or avoid granting, equity-based compensation at certain times. We do not grant equity awards in anticipation of the release of material nonpublic information that is likely to result in changes to the price of our common stock, and do not time the public release of such information based on award grant dates. The timing of any equity grants to executive officers or directors in connection with new hires, promotions, or other non-routine grants is tied to the event giving rise to the award (such as an executive officer’s commencement of employment or promotion effective date). During Fiscal 2025, there were no equity grants made to our executive officers during any period beginning four business days before the filing of a periodic report or current report disclosing material non-public information and ending one business day after the filing or furnishing of such report with the SEC.
|
| Award Timing Method | The timing of any equity grants to executive officers or directors in connection with new hires, promotions, or other non-routine grants is tied to the event giving rise to the award (such as an executive officer’s commencement of employment or promotion effective date). |
| Award Timing Predetermined | true |
| Award Timing MNPI Considered | true |
| Award Timing, How MNPI Considered | We do not have any formal policy that requires the Company to grant, or avoid granting, equity-based compensation at certain times. We do not grant equity awards in anticipation of the release of material nonpublic information that is likely to result in changes to the price of our common stock, and do not time the public release of such information based on award grant dates. The timing of any equity grants to executive officers or directors in connection with new hires, promotions, or other non-routine grants is tied to the event giving rise to the award (such as an executive officer’s commencement of employment or promotion effective date). |
| MNPI Disclosure Timed for Compensation Value | false |
Insider Trading Policies and Procedures |
12 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Insider Trading Policies and Procedures [Line Items] | |
| Insider Trading Policies and Procedures Adopted | true |
{
"version": "2.2",
"instance": {
"vtgn-20250728.htm": {
"nsprefix": "vtgn",
"nsuri": "http://www.vistagen.com/20250728",
"dts": {
"inline": {
"local": [
"vtgn-20250728.htm"
]
},
"schema": {
"local": [
"vtgn-20250728.xsd"
],
"remote": [
"http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
"http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
"http://www.xbrl.org/2003/xl-2003-12-31.xsd",
"http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
"http://www.xbrl.org/2005/xbrldt-2005.xsd",
"http://www.xbrl.org/2006/ref-2006-02-27.xsd",
"http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
"https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
"https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
"https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
"https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
"https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
"https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
"https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
"https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
"https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
"https://xbrl.sec.gov/country/2025/country-2025.xsd",
"https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
"https://xbrl.sec.gov/dei/2025/dei-2025_def.xsd",
"https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd",
"https://xbrl.sec.gov/dei/2025/dei-2025_pre.xsd",
"https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd",
"https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
"https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
"https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
]
},
"definitionLink": {
"local": [
"vtgn-20250728_def.xml"
]
},
"labelLink": {
"local": [
"vtgn-20250728_lab.xml"
]
},
"presentationLink": {
"local": [
"vtgn-20250728_pre.xml"
]
}
},
"keyStandard": 26,
"keyCustom": 0,
"axisStandard": 2,
"axisCustom": 0,
"memberStandard": 8,
"memberCustom": 3,
"hidden": {
"total": 3,
"http://xbrl.sec.gov/dei/2025": 3
},
"contextCount": 63,
"entityCount": 1,
"segmentCount": 11,
"elementCount": 269,
"unitCount": 1,
"baseTaxonomies": {
"http://xbrl.sec.gov/ecd/2025": 87,
"http://xbrl.sec.gov/dei/2025": 4,
"http://fasb.org/us-gaap/2025": 3
},
"report": {
"R1": {
"role": "http://xbrl.sec.gov/dei/role/document/Cover",
"longName": "995100 - Document - Cover",
"shortName": "Cover",
"isDefault": "true",
"groupType": "document",
"subGroupType": "",
"menuCat": "Cover",
"order": "1",
"firstAnchor": {
"contextRef": "c-1",
"name": "dei:EntityRegistrantName",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"div",
"body",
"html"
],
"reportCount": 1,
"baseRef": "vtgn-20250728.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "c-1",
"name": "dei:EntityRegistrantName",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"div",
"body",
"html"
],
"reportCount": 1,
"baseRef": "vtgn-20250728.htm",
"first": true,
"unique": true
}
},
"R2": {
"role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
"longName": "995410 - Disclosure - Pay vs Performance Disclosure",
"shortName": "Pay vs Performance Disclosure",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "2",
"firstAnchor": {
"contextRef": "c-1",
"name": "ecd:PvpTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "vtgn-20250728.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "c-1",
"name": "ecd:PvpTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "vtgn-20250728.htm",
"first": true,
"unique": true
}
},
"R3": {
"role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
"longName": "995443 - Disclosure - Award Timing Disclosure",
"shortName": "Award Timing Disclosure",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "3",
"firstAnchor": {
"contextRef": "c-1",
"name": "ecd:AwardTmgMnpiDiscTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"div",
"body",
"html"
],
"reportCount": 1,
"baseRef": "vtgn-20250728.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "c-1",
"name": "ecd:AwardTmgMnpiDiscTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"div",
"body",
"html"
],
"reportCount": 1,
"baseRef": "vtgn-20250728.htm",
"first": true,
"unique": true
}
},
"R4": {
"role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
"longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
"shortName": "Insider Trading Policies and Procedures",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "4",
"firstAnchor": {
"contextRef": "c-1",
"name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"div",
"body",
"html"
],
"reportCount": 1,
"baseRef": "vtgn-20250728.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "c-1",
"name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"div",
"body",
"html"
],
"reportCount": 1,
"baseRef": "vtgn-20250728.htm",
"first": true,
"unique": true
}
}
},
"tag": {
"ecd_Additional402vDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "Additional402vDisclosureTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Additional 402(v) Disclosure [Text Block]",
"terseLabel": "Additional 402(v) Disclosure"
}
}
},
"auth_ref": [
"r131"
]
},
"dei_AdditionalSecurities462b": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AdditionalSecurities462b",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Additional Securities. 462(b)"
}
}
},
"auth_ref": [
"r187"
]
},
"dei_AdditionalSecurities462bFileNumber": {
"xbrltype": "fileNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AdditionalSecurities462bFileNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Additional Securities, 462(b), File Number"
}
}
},
"auth_ref": [
"r187"
]
},
"dei_AdditionalSecuritiesEffective413b": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AdditionalSecuritiesEffective413b",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Additional Securities Effective, 413(b)"
}
}
},
"auth_ref": [
"r185"
]
},
"dei_AddressTypeDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AddressTypeDomain",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Address Type [Domain]",
"documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
}
}
},
"auth_ref": []
},
"ecd_AdjToCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AdjToCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Adjustment to Compensation Amount",
"terseLabel": "Adjustment to Compensation, Amount"
}
}
},
"auth_ref": [
"r144"
]
},
"ecd_AdjToCompAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AdjToCompAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Adjustment to Compensation [Axis]",
"terseLabel": "Adjustment to Compensation:"
}
}
},
"auth_ref": [
"r144"
]
},
"ecd_AdjToNonPeoNeoCompFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AdjToNonPeoNeoCompFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
"terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
}
}
},
"auth_ref": [
"r144"
]
},
"ecd_AdjToPeoCompFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AdjToPeoCompFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Adjustment To PEO Compensation, Footnote [Text Block]",
"terseLabel": "Adjustment To PEO Compensation, Footnote"
}
}
},
"auth_ref": [
"r144"
]
},
"vtgn_AggregateGrantDateFairValueOfOptionAwardAmountsReportedInSummaryCompensationTableMember": {
"xbrltype": "domainItemType",
"nsuri": "http://www.vistagen.com/20250728",
"localname": "AggregateGrantDateFairValueOfOptionAwardAmountsReportedInSummaryCompensationTableMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Aggregate Grant Date Fair Value of Option Award Amounts Reported in Summary Compensation Table [Member]"
}
}
},
"auth_ref": []
},
"vtgn_AggregateGrantDateFairValueOfStockAwardAmountsReportedInSummaryCompensationTableMember": {
"xbrltype": "domainItemType",
"nsuri": "http://www.vistagen.com/20250728",
"localname": "AggregateGrantDateFairValueOfStockAwardAmountsReportedInSummaryCompensationTableMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Aggregate Grant Date Fair Value of Stock Award Amounts Reported in Summary Compensation Table [Member]"
}
}
},
"auth_ref": []
},
"ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
"terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
}
}
},
"auth_ref": [
"r178"
]
},
"ecd_AggtErrCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AggtErrCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Aggregate Erroneous Compensation Amount",
"terseLabel": "Aggregate Erroneous Compensation Amount"
}
}
},
"auth_ref": [
"r94",
"r105",
"r121",
"r156"
]
},
"ecd_AggtErrCompNotYetDeterminedTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AggtErrCompNotYetDeterminedTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
"terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
}
}
},
"auth_ref": [
"r97",
"r108",
"r124",
"r159"
]
},
"ecd_AggtPnsnAdjsSvcCstMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AggtPnsnAdjsSvcCstMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Aggregate Pension Adjustments Service Cost [Member]",
"terseLabel": "Aggregate Pension Adjustments Service Cost"
}
}
},
"auth_ref": [
"r179"
]
},
"ecd_AllAdjToCompMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AllAdjToCompMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "All Adjustments to Compensation [Member]",
"terseLabel": "All Adjustments to Compensation"
}
}
},
"auth_ref": [
"r144"
]
},
"ecd_AllExecutiveCategoriesMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AllExecutiveCategoriesMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "All Executive Categories [Member]",
"terseLabel": "All Executive Categories"
}
}
},
"auth_ref": [
"r151"
]
},
"ecd_AllIndividualsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AllIndividualsMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "All Individuals [Member]",
"terseLabel": "All Individuals"
}
}
},
"auth_ref": [
"r98",
"r109",
"r125",
"r151",
"r160",
"r164",
"r172"
]
},
"ecd_AllTradingArrangementsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AllTradingArrangementsMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "All Trading Arrangements [Member]",
"terseLabel": "All Trading Arrangements"
}
}
},
"auth_ref": [
"r170"
]
},
"dei_AmendmentDescription": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AmendmentDescription",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Amendment Description",
"documentation": "Description of changes contained within amended document."
}
}
},
"auth_ref": []
},
"dei_AmendmentFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AmendmentFlag",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Amendment Flag",
"documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
}
}
},
"auth_ref": []
},
"dei_AnnualInformationForm": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AnnualInformationForm",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Annual Information Form",
"documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
}
}
},
"auth_ref": [
"r101"
]
},
"dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
"xbrltype": "dateOrAsapItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Approximate Date of Commencement of Proposed Sale to Public",
"documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
}
}
},
"auth_ref": []
},
"dei_AuditedAnnualFinancialStatements": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AuditedAnnualFinancialStatements",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Audited Annual Financial Statements",
"documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
}
}
},
"auth_ref": [
"r101"
]
},
"dei_AuditorFirmId": {
"xbrltype": "nonemptySequenceNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AuditorFirmId",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/AuditInformation"
],
"lang": {
"en-us": {
"role": {
"label": "Auditor Firm ID",
"documentation": "PCAOB issued Audit Firm Identifier"
}
}
},
"auth_ref": [
"r86",
"r89",
"r101"
]
},
"dei_AuditorLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AuditorLineItems",
"lang": {
"en-us": {
"role": {
"label": "Auditor [Line Items]"
}
}
},
"auth_ref": []
},
"dei_AuditorLocation": {
"xbrltype": "internationalNameItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AuditorLocation",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/AuditInformation"
],
"lang": {
"en-us": {
"role": {
"label": "Auditor Location"
}
}
},
"auth_ref": [
"r86",
"r89",
"r101"
]
},
"dei_AuditorName": {
"xbrltype": "internationalNameItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AuditorName",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/AuditInformation"
],
"lang": {
"en-us": {
"role": {
"label": "Auditor Name"
}
}
},
"auth_ref": [
"r86",
"r89",
"r101"
]
},
"dei_AuditorOpinionTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AuditorOpinionTextBlock",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/AuditInformation"
],
"lang": {
"en-us": {
"role": {
"label": "Auditor Opinion [Text Block]"
}
}
},
"auth_ref": [
"r183"
]
},
"dei_AuditorTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AuditorTable",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/AuditInformation"
],
"lang": {
"en-us": {
"role": {
"label": "Auditor [Table]"
}
}
},
"auth_ref": []
},
"ecd_AwardExrcPrice": {
"xbrltype": "perShareItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AwardExrcPrice",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Exercise Price",
"terseLabel": "Exercise Price"
}
}
},
"auth_ref": [
"r167"
]
},
"ecd_AwardGrantDateFairValue": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AwardGrantDateFairValue",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Grant Date Fair Value",
"terseLabel": "Fair Value as of Grant Date"
}
}
},
"auth_ref": [
"r168"
]
},
"ecd_AwardTmgDiscLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AwardTmgDiscLineItems",
"lang": {
"en-us": {
"role": {
"label": "Award Timing Disclosures [Line Items]",
"terseLabel": "Award Timing Disclosures"
}
}
},
"auth_ref": [
"r163"
]
},
"ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AwardTmgHowMnpiCnsdrdTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Timing, How MNPI Considered [Text Block]",
"terseLabel": "Award Timing, How MNPI Considered"
}
}
},
"auth_ref": [
"r163"
]
},
"ecd_AwardTmgMethodTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AwardTmgMethodTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Timing Method [Text Block]",
"terseLabel": "Award Timing Method"
}
}
},
"auth_ref": [
"r163"
]
},
"ecd_AwardTmgMnpiCnsdrdFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AwardTmgMnpiCnsdrdFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Timing MNPI Considered [Flag]",
"terseLabel": "Award Timing MNPI Considered"
}
}
},
"auth_ref": [
"r163"
]
},
"ecd_AwardTmgMnpiDiscTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AwardTmgMnpiDiscTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Timing MNPI Disclosure [Text Block]",
"terseLabel": "Award Timing MNPI Disclosure"
}
}
},
"auth_ref": [
"r163"
]
},
"ecd_AwardTmgPredtrmndFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AwardTmgPredtrmndFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Timing Predetermined [Flag]",
"terseLabel": "Award Timing Predetermined"
}
}
},
"auth_ref": [
"r163"
]
},
"us-gaap_AwardTypeAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2025",
"localname": "AwardTypeAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Type [Axis]",
"terseLabel": "Award Type",
"documentation": "Information by type of award under share-based payment arrangement."
}
}
},
"auth_ref": [
"r35",
"r36",
"r37",
"r38",
"r39",
"r40",
"r41",
"r42",
"r43",
"r44",
"r45",
"r46",
"r47",
"r48",
"r49",
"r50",
"r51",
"r52",
"r53",
"r54",
"r55",
"r56",
"r57",
"r58",
"r59",
"r60"
]
},
"ecd_AwardUndrlygSecuritiesAmt": {
"xbrltype": "decimalItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AwardUndrlygSecuritiesAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Underlying Securities Amount",
"terseLabel": "Underlying Securities"
}
}
},
"auth_ref": [
"r166"
]
},
"ecd_AwardsCloseToMnpiDiscIndName": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AwardsCloseToMnpiDiscIndName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Awards Close in Time to MNPI Disclosures, Individual Name",
"terseLabel": "Name"
}
}
},
"auth_ref": [
"r165"
]
},
"ecd_AwardsCloseToMnpiDiscTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AwardsCloseToMnpiDiscTable",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Awards Close in Time to MNPI Disclosures [Table]",
"terseLabel": "Awards Close in Time to MNPI Disclosures"
}
}
},
"auth_ref": [
"r164"
]
},
"ecd_AwardsCloseToMnpiDiscTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "AwardsCloseToMnpiDiscTableTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
"terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
}
}
},
"auth_ref": [
"r164"
]
},
"dei_BusinessContactMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "BusinessContactMember",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Business Contact [Member]",
"documentation": "Business contact for the entity"
}
}
},
"auth_ref": [
"r89",
"r101"
]
},
"ecd_ChangedPeerGroupFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "ChangedPeerGroupFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Changed Peer Group, Footnote [Text Block]",
"terseLabel": "Changed Peer Group, Footnote"
}
}
},
"auth_ref": [
"r142"
]
},
"ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
"terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
}
}
},
"auth_ref": [
"r139"
]
},
"ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
"terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
}
}
},
"auth_ref": [
"r137"
]
},
"dei_CityAreaCode": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "CityAreaCode",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "City Area Code",
"documentation": "Area code of city"
}
}
},
"auth_ref": []
},
"ecd_CoSelectedMeasureAmt": {
"xbrltype": "decimalItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "CoSelectedMeasureAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Company Selected Measure Amount",
"terseLabel": "Company Selected Measure Amount"
}
}
},
"auth_ref": [
"r143"
]
},
"ecd_CoSelectedMeasureName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "CoSelectedMeasureName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Company Selected Measure Name",
"terseLabel": "Company Selected Measure Name"
}
}
},
"auth_ref": [
"r143"
]
},
"ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
"terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
}
}
},
"auth_ref": [
"r148"
]
},
"ecd_CompActuallyPaidVsNetIncomeTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "CompActuallyPaidVsNetIncomeTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Compensation Actually Paid vs. Net Income [Text Block]",
"terseLabel": "Compensation Actually Paid vs. Net Income"
}
}
},
"auth_ref": [
"r147"
]
},
"ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "CompActuallyPaidVsOtherMeasureTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Compensation Actually Paid vs. Other Measure [Text Block]",
"terseLabel": "Compensation Actually Paid vs. Other Measure"
}
}
},
"auth_ref": [
"r149"
]
},
"ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
"terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
}
}
},
"auth_ref": [
"r146"
]
},
"dei_ContactPersonnelEmailAddress": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "ContactPersonnelEmailAddress",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Contact Personnel Email Address",
"documentation": "Email address of contact personnel."
}
}
},
"auth_ref": []
},
"dei_ContactPersonnelFaxNumber": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "ContactPersonnelFaxNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Contact Personnel Fax Number",
"documentation": "Fax Number of contact personnel."
}
}
},
"auth_ref": [
"r89"
]
},
"dei_ContactPersonnelName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "ContactPersonnelName",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Contact Personnel Name",
"documentation": "Name of contact personnel"
}
}
},
"auth_ref": []
},
"dei_ContainedFileInformationFileDescription": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "ContainedFileInformationFileDescription",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Contained File Information, File Description",
"documentation": "The description of the contained file."
}
}
},
"auth_ref": []
},
"dei_ContainedFileInformationFileName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "ContainedFileInformationFileName",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Contained File Information, File Name",
"documentation": "The name of the contained file."
}
}
},
"auth_ref": []
},
"dei_ContainedFileInformationFileNumber": {
"xbrltype": "fileNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "ContainedFileInformationFileNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Contained File Information, File Number",
"documentation": "The SEC Document Number of the contained file."
}
}
},
"auth_ref": []
},
"dei_ContainedFileInformationFileType": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "ContainedFileInformationFileType",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Contained File Information, File Type",
"documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
}
}
},
"auth_ref": []
},
"dei_CountryRegion": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "CountryRegion",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Country Region",
"documentation": "Region code of country"
}
}
},
"auth_ref": []
},
"dei_CoverAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "CoverAbstract",
"lang": {
"en-us": {
"role": {
"label": "Cover [Abstract]",
"documentation": "Cover page."
}
}
},
"auth_ref": []
},
"dei_CurrentFiscalYearEndDate": {
"xbrltype": "gMonthDayItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "CurrentFiscalYearEndDate",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Current Fiscal Year End Date",
"documentation": "End date of current fiscal year in the format --MM-DD."
}
}
},
"auth_ref": []
},
"dei_DelayedOrContinuousOffering": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DelayedOrContinuousOffering",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Delayed or Continuous Offering"
}
}
},
"auth_ref": [
"r113",
"r114",
"r128"
]
},
"dei_DividendOrInterestReinvestmentPlanOnly": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DividendOrInterestReinvestmentPlanOnly",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Dividend or Interest Reinvestment Plan Only"
}
}
},
"auth_ref": [
"r113",
"r114",
"r128"
]
},
"dei_DocumentAccountingStandard": {
"xbrltype": "accountingStandardItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentAccountingStandard",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Accounting Standard",
"documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
}
}
},
"auth_ref": [
"r89"
]
},
"dei_DocumentAnnualReport": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentAnnualReport",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Annual Report",
"documentation": "Boolean flag that is true only for a form used as an annual report."
}
}
},
"auth_ref": [
"r86",
"r89",
"r101"
]
},
"dei_DocumentCopyrightInformation": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentCopyrightInformation",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Copyright Information",
"documentation": "The copyright information for the document."
}
}
},
"auth_ref": []
},
"dei_DocumentCreationDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentCreationDate",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Creation Date",
"documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
}
}
},
"auth_ref": []
},
"dei_DocumentDescription": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentDescription",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Description",
"documentation": "The description of the document."
}
}
},
"auth_ref": []
},
"dei_DocumentDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentDomain",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document [Domain]",
"documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
}
}
},
"auth_ref": []
},
"dei_DocumentEffectiveDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentEffectiveDate",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Effective Date",
"documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
}
}
},
"auth_ref": []
},
"dei_DocumentFinStmtErrorCorrectionFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentFinStmtErrorCorrectionFlag",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Financial Statement Error Correction [Flag]",
"documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
}
}
},
"auth_ref": [
"r86",
"r89",
"r101",
"r152"
]
},
"dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
"documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
}
}
},
"auth_ref": [
"r86",
"r89",
"r101",
"r152"
]
},
"dei_DocumentFiscalPeriodFocus": {
"xbrltype": "fiscalPeriodItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentFiscalPeriodFocus",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Fiscal Period Focus",
"documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
}
}
},
"auth_ref": []
},
"dei_DocumentFiscalYearFocus": {
"xbrltype": "gYearItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentFiscalYearFocus",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Fiscal Year Focus",
"documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
}
}
},
"auth_ref": []
},
"dei_DocumentInformationDocumentAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentInformationDocumentAxis",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Information, Document [Axis]",
"documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
}
}
},
"auth_ref": []
},
"dei_DocumentInformationLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentInformationLineItems",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Information [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": []
},
"dei_DocumentInformationTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentInformationTable",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Information [Table]",
"documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
}
}
},
"auth_ref": []
},
"dei_DocumentInformationTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentInformationTextBlock",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Information [Text Block]",
"documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
}
}
},
"auth_ref": []
},
"dei_DocumentName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentName",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Name",
"documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the <FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
}
}
},
"auth_ref": []
},
"dei_DocumentPeriodEndDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentPeriodEndDate",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Period End Date",
"documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
}
}
},
"auth_ref": []
},
"dei_DocumentPeriodStartDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentPeriodStartDate",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Period Start Date",
"documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
}
}
},
"auth_ref": []
},
"dei_DocumentQuarterlyReport": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentQuarterlyReport",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Quarterly Report",
"documentation": "Boolean flag that is true only for a form used as an quarterly report."
}
}
},
"auth_ref": [
"r87"
]
},
"dei_DocumentRegistrationStatement": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentRegistrationStatement",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Registration Statement",
"documentation": "Boolean flag that is true only for a form used as a registration statement."
}
}
},
"auth_ref": [
"r75"
]
},
"dei_DocumentShellCompanyEventDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentShellCompanyEventDate",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Shell Company Event Date",
"documentation": "Date of event requiring a shell company report."
}
}
},
"auth_ref": [
"r89"
]
},
"dei_DocumentShellCompanyReport": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentShellCompanyReport",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Shell Company Report",
"documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
}
}
},
"auth_ref": [
"r89"
]
},
"dei_DocumentSubtitle": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentSubtitle",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Subtitle",
"documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
}
}
},
"auth_ref": []
},
"dei_DocumentSynopsis": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentSynopsis",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Synopsis",
"documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
}
}
},
"auth_ref": []
},
"dei_DocumentTitle": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentTitle",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Title",
"documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
}
}
},
"auth_ref": []
},
"dei_DocumentTransitionReport": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentTransitionReport",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Transition Report",
"documentation": "Boolean flag that is true only for a form used as a transition report."
}
}
},
"auth_ref": [
"r129"
]
},
"dei_DocumentType": {
"xbrltype": "submissionTypeItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentType",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Type",
"documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
}
}
},
"auth_ref": []
},
"dei_DocumentVersion": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentVersion",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Version",
"documentation": "The version identifier of the document."
}
}
},
"auth_ref": []
},
"dei_DocumentsIncorporatedByReferenceTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentsIncorporatedByReferenceTextBlock",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Documents Incorporated by Reference [Text Block]",
"documentation": "Documents incorporated by reference."
}
}
},
"auth_ref": [
"r78"
]
},
"ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
"terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
}
}
},
"auth_ref": [
"r141"
]
},
"dei_EffectiveAfter60Days486a": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EffectiveAfter60Days486a",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Effective after 60 Days, 486(a)"
}
}
},
"auth_ref": [
"r191"
]
},
"dei_EffectiveOnDate486a": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EffectiveOnDate486a",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Effective on Date, 486(a)"
}
}
},
"auth_ref": [
"r191"
]
},
"dei_EffectiveOnDate486b": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EffectiveOnDate486b",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Effective on Date, 486(b)"
}
}
},
"auth_ref": [
"r192"
]
},
"dei_EffectiveOnSetDate486a": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EffectiveOnSetDate486a",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Effective on Set Date, 486(a)"
}
}
},
"auth_ref": [
"r191"
]
},
"dei_EffectiveOnSetDate486b": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EffectiveOnSetDate486b",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Effective on Set Date, 486(b)"
}
}
},
"auth_ref": [
"r192"
]
},
"dei_EffectiveUponFiling462e": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EffectiveUponFiling462e",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Effective Upon Filing, 462(e)"
}
}
},
"auth_ref": [
"r190"
]
},
"dei_EffectiveUponFiling486b": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EffectiveUponFiling486b",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Effective upon Filing, 486(b)"
}
}
},
"auth_ref": [
"r192"
]
},
"dei_EffectiveWhenDeclaredSection8c": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EffectiveWhenDeclaredSection8c",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Effective when Declared, Section 8(c)"
}
}
},
"auth_ref": [
"r194"
]
},
"us-gaap_EmployeeStockOptionMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2025",
"localname": "EmployeeStockOptionMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Employee Stock Option [Member]",
"terseLabel": "Employee Stock Option",
"documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
}
}
},
"auth_ref": [
"r196",
"r197",
"r198",
"r199",
"r200",
"r201",
"r202",
"r203",
"r204",
"r205",
"r206",
"r207",
"r208",
"r209",
"r210",
"r211",
"r212",
"r213",
"r214",
"r215",
"r216",
"r217",
"r218",
"r219",
"r220",
"r221"
]
},
"dei_EntitiesTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntitiesTable",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entities [Table]",
"documentation": "Container to assemble all relevant information about each entity associated with the document instance"
}
}
},
"auth_ref": []
},
"dei_EntityAccountingStandard": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAccountingStandard",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Accounting Standard",
"documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
}
}
},
"auth_ref": []
},
"dei_EntityAddressAddressDescription": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressAddressDescription",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Address Description",
"documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
}
}
},
"auth_ref": []
},
"dei_EntityAddressAddressLine1": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressAddressLine1",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Address Line One",
"documentation": "Address Line 1 such as Attn, Building Name, Street Name"
}
}
},
"auth_ref": []
},
"dei_EntityAddressAddressLine2": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressAddressLine2",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Address Line Two",
"documentation": "Address Line 2 such as Street or Suite number"
}
}
},
"auth_ref": []
},
"dei_EntityAddressAddressLine3": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressAddressLine3",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Address Line Three",
"documentation": "Address Line 3 such as an Office Park"
}
}
},
"auth_ref": []
},
"dei_EntityAddressCityOrTown": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressCityOrTown",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, City or Town",
"documentation": "Name of the City or Town"
}
}
},
"auth_ref": []
},
"dei_EntityAddressCountry": {
"xbrltype": "countryCodeItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressCountry",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Country",
"documentation": "ISO 3166-1 alpha-2 country code."
}
}
},
"auth_ref": []
},
"dei_EntityAddressPostalZipCode": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressPostalZipCode",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Postal Zip Code",
"documentation": "Code for the postal or zip code"
}
}
},
"auth_ref": []
},
"dei_EntityAddressStateOrProvince": {
"xbrltype": "stateOrProvinceItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressStateOrProvince",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, State or Province",
"documentation": "Name of the state or province."
}
}
},
"auth_ref": []
},
"dei_EntityAddressesAddressTypeAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressesAddressTypeAxis",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Addresses, Address Type [Axis]",
"documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
}
}
},
"auth_ref": []
},
"dei_EntityAddressesLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressesLineItems",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Addresses [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": []
},
"dei_EntityAddressesTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressesTable",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Addresses [Table]",
"documentation": "Container of address information for the entity"
}
}
},
"auth_ref": [
"r77"
]
},
"dei_EntityBankruptcyProceedingsReportingCurrent": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityBankruptcyProceedingsReportingCurrent",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Bankruptcy Proceedings, Reporting Current",
"documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
}
}
},
"auth_ref": [
"r81"
]
},
"dei_EntityCentralIndexKey": {
"xbrltype": "centralIndexKeyItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityCentralIndexKey",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Central Index Key",
"documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
}
}
},
"auth_ref": [
"r77"
]
},
"dei_EntityCommonStockSharesOutstanding": {
"xbrltype": "sharesItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityCommonStockSharesOutstanding",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Common Stock, Shares Outstanding",
"documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
}
}
},
"auth_ref": []
},
"dei_EntityContactPersonnelLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityContactPersonnelLineItems",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Contact Personnel [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": []
},
"dei_EntityCurrentReportingStatus": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityCurrentReportingStatus",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Current Reporting Status",
"documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
}
}
},
"auth_ref": []
},
"dei_EntityDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityDomain",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/AuditInformation",
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity [Domain]",
"documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
}
}
},
"auth_ref": []
},
"dei_EntityEmergingGrowthCompany": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityEmergingGrowthCompany",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Emerging Growth Company",
"documentation": "Indicate if registrant meets the emerging growth company criteria."
}
}
},
"auth_ref": [
"r77"
]
},
"dei_EntityExTransitionPeriod": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityExTransitionPeriod",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Ex Transition Period",
"documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
}
}
},
"auth_ref": [
"r193"
]
},
"dei_EntityFileNumber": {
"xbrltype": "fileNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityFileNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity File Number",
"documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
}
}
},
"auth_ref": []
},
"dei_EntityFilerCategory": {
"xbrltype": "filerCategoryItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityFilerCategory",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Filer Category",
"documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
}
}
},
"auth_ref": [
"r77"
]
},
"dei_EntityHomeCountryISOCode": {
"xbrltype": "countryCodeItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityHomeCountryISOCode",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Home Country ISO Code",
"documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
}
}
},
"auth_ref": []
},
"dei_EntityIncorporationDateOfIncorporation": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityIncorporationDateOfIncorporation",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Incorporation, Date of Incorporation",
"documentation": "Date when an entity was incorporated"
}
}
},
"auth_ref": []
},
"dei_EntityIncorporationStateCountryCode": {
"xbrltype": "edgarStateCountryItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityIncorporationStateCountryCode",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Incorporation, State or Country Code",
"documentation": "Two-character EDGAR code representing the state or country of incorporation."
}
}
},
"auth_ref": []
},
"dei_EntityInformationFormerLegalOrRegisteredName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityInformationFormerLegalOrRegisteredName",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Information, Former Legal or Registered Name",
"documentation": "Former Legal or Registered Name of an entity"
}
}
},
"auth_ref": []
},
"dei_EntityInformationLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityInformationLineItems",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Information [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": []
},
"dei_EntityInteractiveDataCurrent": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityInteractiveDataCurrent",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Interactive Data Current",
"documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
}
}
},
"auth_ref": [
"r182"
]
},
"dei_EntityInvCompanyType": {
"xbrltype": "invCompanyType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityInvCompanyType",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Inv Company Type",
"documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
}
}
},
"auth_ref": [
"r181"
]
},
"dei_EntityLegalForm": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityLegalForm",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Legal Form",
"documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
}
}
},
"auth_ref": []
},
"dei_EntityListingDepositoryReceiptRatio": {
"xbrltype": "pureItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityListingDepositoryReceiptRatio",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Listing, Depository Receipt Ratio",
"documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
}
}
},
"auth_ref": []
},
"dei_EntityListingDescription": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityListingDescription",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Listing, Description",
"documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
}
}
},
"auth_ref": []
},
"dei_EntityListingForeign": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityListingForeign",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Listing, Foreign",
"documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
}
}
},
"auth_ref": []
},
"dei_EntityListingParValuePerShare": {
"xbrltype": "perShareItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityListingParValuePerShare",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Listing, Par Value Per Share",
"documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
}
}
},
"auth_ref": []
},
"dei_EntityListingPrimary": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityListingPrimary",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Listing, Primary",
"documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
}
}
},
"auth_ref": []
},
"dei_EntityListingSecurityTradingCurrency": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityListingSecurityTradingCurrency",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Listing, Security Trading Currency",
"documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
}
}
},
"auth_ref": []
},
"dei_EntityListingsExchangeAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityListingsExchangeAxis",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Listings, Exchange [Axis]",
"documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
}
}
},
"auth_ref": []
},
"dei_EntityListingsLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityListingsLineItems",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Listings [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": []
},
"dei_EntityListingsTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityListingsTable",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Listings [Table]",
"documentation": "Container for exchange listing information for an entity"
}
}
},
"auth_ref": []
},
"dei_EntityNumberOfEmployees": {
"xbrltype": "decimalItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityNumberOfEmployees",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Number of Employees",
"documentation": "Number of persons employed by the Entity"
}
}
},
"auth_ref": []
},
"dei_EntityPhoneFaxNumbersLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityPhoneFaxNumbersLineItems",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Phone Fax Numbers [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": []
},
"dei_EntityPrimarySicNumber": {
"xbrltype": "sicNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityPrimarySicNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Primary SIC Number",
"documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
}
}
},
"auth_ref": [
"r101"
]
},
"dei_EntityPublicFloat": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityPublicFloat",
"crdr": "credit",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Public Float",
"documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
}
}
},
"auth_ref": []
},
"dei_EntityRegistrantName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityRegistrantName",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Registrant Name",
"documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
}
}
},
"auth_ref": [
"r77"
]
},
"dei_EntityReportingCurrencyISOCode": {
"xbrltype": "currencyItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityReportingCurrencyISOCode",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Reporting Currency ISO Code",
"documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
}
}
},
"auth_ref": []
},
"dei_EntityShellCompany": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityShellCompany",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Shell Company",
"documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
}
}
},
"auth_ref": [
"r77"
]
},
"dei_EntitySmallBusiness": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntitySmallBusiness",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Small Business",
"documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
}
}
},
"auth_ref": [
"r77"
]
},
"dei_EntityTaxIdentificationNumber": {
"xbrltype": "employerIdItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityTaxIdentificationNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Tax Identification Number",
"documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
}
}
},
"auth_ref": [
"r77"
]
},
"dei_EntityTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityTextBlock",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity [Text Block]",
"documentation": "Container to serve as parent of six Entity related Table concepts."
}
}
},
"auth_ref": []
},
"dei_EntityVoluntaryFilers": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityVoluntaryFilers",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Voluntary Filers",
"documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
}
}
},
"auth_ref": []
},
"dei_EntityWellKnownSeasonedIssuer": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityWellKnownSeasonedIssuer",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Well-known Seasoned Issuer",
"documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
}
}
},
"auth_ref": [
"r184"
]
},
"ecd_EqtyAwrdsAdjFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "EqtyAwrdsAdjFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Equity Awards Adjustments, Footnote [Text Block]",
"terseLabel": "Equity Awards Adjustments, Footnote"
}
}
},
"auth_ref": [
"r135"
]
},
"ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
"terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
}
}
},
"auth_ref": [
"r177"
]
},
"ecd_EqtyAwrdsAdjsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "EqtyAwrdsAdjsMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Equity Awards Adjustments [Member]",
"terseLabel": "Equity Awards Adjustments"
}
}
},
"auth_ref": [
"r177"
]
},
"ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
"terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
}
}
},
"auth_ref": [
"r177"
]
},
"ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "EquityValuationAssumptionDifferenceFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
"terseLabel": "Equity Valuation Assumption Difference, Footnote"
}
}
},
"auth_ref": [
"r145"
]
},
"ecd_ErrCompAnalysisTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "ErrCompAnalysisTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Erroneous Compensation Analysis [Text Block]",
"terseLabel": "Erroneous Compensation Analysis"
}
}
},
"auth_ref": [
"r94",
"r105",
"r121",
"r156"
]
},
"ecd_ErrCompRecoveryTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "ErrCompRecoveryTable",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Erroneously Awarded Compensation Recovery [Table]",
"terseLabel": "Erroneously Awarded Compensation Recovery"
}
}
},
"auth_ref": [
"r91",
"r102",
"r118",
"r153"
]
},
"dei_ExchangeDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "ExchangeDomain",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Exchange [Domain]",
"documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
}
}
},
"auth_ref": []
},
"ecd_ExecutiveCategoryAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "ExecutiveCategoryAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Executive Category [Axis]",
"terseLabel": "Executive Category:"
}
}
},
"auth_ref": [
"r151"
]
},
"dei_ExhibitsOnly462d": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "ExhibitsOnly462d",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Exhibits Only, 462(d)"
}
}
},
"auth_ref": [
"r189"
]
},
"dei_ExhibitsOnly462dFileNumber": {
"xbrltype": "fileNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "ExhibitsOnly462dFileNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Exhibits Only, 462(d), File Number"
}
}
},
"auth_ref": [
"r189"
]
},
"dei_Extension": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "Extension",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Extension",
"documentation": "Extension number for local phone number."
}
}
},
"auth_ref": []
},
"ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
"terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
}
}
},
"auth_ref": [
"r98",
"r109",
"r125",
"r160"
]
},
"ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Forgone Recovery due to Expense of Enforcement, Amount",
"terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
}
}
},
"auth_ref": [
"r98",
"r109",
"r125",
"r160"
]
},
"ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Forgone Recovery due to Violation of Home Country Law, Amount",
"terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
}
}
},
"auth_ref": [
"r98",
"r109",
"r125",
"r160"
]
},
"ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
"terseLabel": "Forgone Recovery, Explanation of Impracticability"
}
}
},
"auth_ref": [
"r98",
"r109",
"r125",
"r160"
]
},
"ecd_ForgoneRecoveryIndName": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "ForgoneRecoveryIndName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Forgone Recovery, Individual Name",
"terseLabel": "Name"
}
}
},
"auth_ref": [
"r98",
"r109",
"r125",
"r160"
]
},
"dei_FormerAddressMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "FormerAddressMember",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Former Address [Member]",
"documentation": "Former address for entity"
}
}
},
"auth_ref": [
"r88",
"r112"
]
},
"dei_FormerFiscalYearEndDate": {
"xbrltype": "gMonthDayItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "FormerFiscalYearEndDate",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Former Fiscal Year End Date",
"documentation": "Former end date of previous fiscal years"
}
}
},
"auth_ref": []
},
"ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
"terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
}
}
},
"auth_ref": [
"r140"
]
},
"dei_IcfrAuditorAttestationFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "IcfrAuditorAttestationFlag",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "ICFR Auditor Attestation Flag"
}
}
},
"auth_ref": [
"r86",
"r89",
"r101"
]
},
"ecd_IndividualAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "IndividualAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Individual [Axis]",
"terseLabel": "Individual:"
}
}
},
"auth_ref": [
"r98",
"r109",
"r125",
"r151",
"r160",
"r164",
"r172"
]
},
"ecd_InsiderTradingArrLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "InsiderTradingArrLineItems",
"lang": {
"en-us": {
"role": {
"label": "Insider Trading Arrangements [Line Items]",
"terseLabel": "Insider Trading Arrangements:"
}
}
},
"auth_ref": [
"r170"
]
},
"ecd_InsiderTradingPoliciesProcLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "InsiderTradingPoliciesProcLineItems",
"lang": {
"en-us": {
"role": {
"label": "Insider Trading Policies and Procedures [Line Items]",
"terseLabel": "Insider Trading Policies and Procedures:"
}
}
},
"auth_ref": [
"r90",
"r176"
]
},
"ecd_InsiderTrdPoliciesProcAdoptedFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "InsiderTrdPoliciesProcAdoptedFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
],
"lang": {
"en-us": {
"role": {
"label": "Insider Trading Policies and Procedures Adopted [Flag]",
"terseLabel": "Insider Trading Policies and Procedures Adopted"
}
}
},
"auth_ref": [
"r90",
"r176"
]
},
"ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
],
"lang": {
"en-us": {
"role": {
"label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
"terseLabel": "Insider Trading Policies and Procedures Not Adopted"
}
}
},
"auth_ref": [
"r90",
"r176"
]
},
"dei_InvestmentCompanyActFileNumber": {
"xbrltype": "fileNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "InvestmentCompanyActFileNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Investment Company Act File Number"
}
}
},
"auth_ref": [
"r114",
"r115",
"r116",
"r117"
]
},
"dei_InvestmentCompanyActRegistration": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "InvestmentCompanyActRegistration",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Investment Company Act Registration"
}
}
},
"auth_ref": [
"r130"
]
},
"dei_InvestmentCompanyRegistrationAmendment": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "InvestmentCompanyRegistrationAmendment",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Investment Company Registration Amendment"
}
}
},
"auth_ref": [
"r130"
]
},
"dei_InvestmentCompanyRegistrationAmendmentNumber": {
"xbrltype": "sequenceNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "InvestmentCompanyRegistrationAmendmentNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Investment Company Registration Amendment Number"
}
}
},
"auth_ref": [
"r130"
]
},
"dei_LegalEntityAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "LegalEntityAxis",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/AuditInformation",
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Legal Entity [Axis]",
"documentation": "The set of legal entities associated with a report."
}
}
},
"auth_ref": []
},
"dei_LegalEntityIdentifier": {
"xbrltype": "legalEntityIdentifierItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "LegalEntityIdentifier",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Legal Entity Identifier",
"documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
}
}
},
"auth_ref": [
"r74"
]
},
"dei_LocalPhoneNumber": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "LocalPhoneNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Local Phone Number",
"documentation": "Local phone number for entity."
}
}
},
"auth_ref": []
},
"ecd_MeasureAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "MeasureAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Measure [Axis]",
"terseLabel": "Measure:"
}
}
},
"auth_ref": [
"r143"
]
},
"ecd_MeasureName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "MeasureName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Measure Name",
"terseLabel": "Name"
}
}
},
"auth_ref": [
"r143"
]
},
"ecd_MnpiDiscTimedForCompValFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "MnpiDiscTimedForCompValFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "MNPI Disclosure Timed for Compensation Value [Flag]",
"terseLabel": "MNPI Disclosure Timed for Compensation Value"
}
}
},
"auth_ref": [
"r163"
]
},
"ecd_MtrlTermsOfTrdArrTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "MtrlTermsOfTrdArrTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Material Terms of Trading Arrangement [Text Block]",
"terseLabel": "Material Terms of Trading Arrangement"
}
}
},
"auth_ref": [
"r171"
]
},
"dei_NameChangeEventDateAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "NameChangeEventDateAxis",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Name Change Event Date [Axis]",
"documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
}
}
},
"auth_ref": []
},
"dei_NameChangeEventLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "NameChangeEventLineItems",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Name Change Event [Line Items]",
"documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
}
}
},
"auth_ref": []
},
"dei_NameChangeEventTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "NameChangeEventTable",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Name Change Event [Table]",
"documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
}
}
},
"auth_ref": []
},
"ecd_NamedExecutiveOfficersFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "NamedExecutiveOfficersFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Named Executive Officers, Footnote [Text Block]",
"terseLabel": "Named Executive Officers, Footnote"
}
}
},
"auth_ref": [
"r144"
]
},
"us-gaap_NetIncomeLoss": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2025",
"localname": "NetIncomeLoss",
"crdr": "credit",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Net Income (Loss)",
"terseLabel": "Net Income (Loss)",
"documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
}
}
},
"auth_ref": [
"r0",
"r1",
"r2",
"r3",
"r4",
"r5",
"r6",
"r7",
"r8",
"r9",
"r10",
"r11",
"r12",
"r13",
"r14",
"r15",
"r16",
"r17",
"r18",
"r19",
"r20",
"r21",
"r22",
"r23",
"r24",
"r25",
"r26",
"r27",
"r28",
"r29",
"r30",
"r31",
"r32",
"r33",
"r34",
"r61",
"r62",
"r63",
"r64",
"r65",
"r66",
"r67",
"r68",
"r69",
"r70",
"r71",
"r72",
"r73",
"r195"
]
},
"dei_NewEffectiveDateForPreviousFiling": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "NewEffectiveDateForPreviousFiling",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "New Effective Date for Previous Filing"
}
}
},
"auth_ref": [
"r114",
"r115",
"r116",
"r117"
]
},
"dei_NoSubstantiveChanges462c": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "NoSubstantiveChanges462c",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "No Substantive Changes, 462(c)"
}
}
},
"auth_ref": [
"r188"
]
},
"dei_NoSubstantiveChanges462cFileNumber": {
"xbrltype": "fileNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "NoSubstantiveChanges462cFileNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "No Substantive Changes, 462(c), File Number"
}
}
},
"auth_ref": [
"r188"
]
},
"dei_NoTradingSymbolFlag": {
"xbrltype": "trueItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "NoTradingSymbolFlag",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "No Trading Symbol Flag",
"documentation": "Boolean flag that is true only for a security having no trading symbol."
}
}
},
"auth_ref": []
},
"ecd_NonGaapMeasureDescriptionTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "NonGaapMeasureDescriptionTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Non-GAAP Measure Description [Text Block]",
"terseLabel": "Non-GAAP Measure Description"
}
}
},
"auth_ref": [
"r143"
]
},
"ecd_NonNeosMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "NonNeosMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Non-NEOs [Member]",
"terseLabel": "Non-NEOs"
}
}
},
"auth_ref": [
"r98",
"r109",
"r125",
"r151",
"r160"
]
},
"ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "NonPeoNeoAvgCompActuallyPaidAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Non-PEO NEO Average Compensation Actually Paid Amount",
"terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
}
}
},
"auth_ref": [
"r134"
]
},
"ecd_NonPeoNeoAvgTotalCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "NonPeoNeoAvgTotalCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Non-PEO NEO Average Total Compensation Amount",
"terseLabel": "Non-PEO NEO Average Total Compensation Amount"
}
}
},
"auth_ref": [
"r133"
]
},
"ecd_NonPeoNeoMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "NonPeoNeoMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Non-PEO NEO [Member]",
"terseLabel": "Non-PEO NEO"
}
}
},
"auth_ref": [
"r151"
]
},
"ecd_NonRule10b51ArrAdoptedFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "NonRule10b51ArrAdoptedFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
"terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
}
}
},
"auth_ref": [
"r171"
]
},
"ecd_NonRule10b51ArrTrmntdFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "NonRule10b51ArrTrmntdFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
"terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
}
}
},
"auth_ref": [
"r171"
]
},
"dei_OtherAddressMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "OtherAddressMember",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Other Address [Member]",
"documentation": "Other address for entity"
}
}
},
"auth_ref": []
},
"ecd_OtherPerfMeasureAmt": {
"xbrltype": "decimalItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "OtherPerfMeasureAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Other Performance Measure, Amount",
"terseLabel": "Other Performance Measure, Amount"
}
}
},
"auth_ref": [
"r143"
]
},
"dei_OtherReportingStandardItemNumber": {
"xbrltype": "otherReportingStandardItemNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "OtherReportingStandardItemNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Other Reporting Standard Item Number",
"documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
}
}
},
"auth_ref": [
"r89"
]
},
"ecd_OutstandingAggtErrCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "OutstandingAggtErrCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Outstanding Aggregate Erroneous Compensation Amount",
"terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
}
}
},
"auth_ref": [
"r96",
"r107",
"r123",
"r158"
]
},
"ecd_OutstandingRecoveryCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "OutstandingRecoveryCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Outstanding Recovery Compensation Amount",
"terseLabel": "Compensation Amount"
}
}
},
"auth_ref": [
"r99",
"r110",
"r126",
"r161"
]
},
"ecd_OutstandingRecoveryIndName": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "OutstandingRecoveryIndName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Outstanding Recovery, Individual Name",
"terseLabel": "Name"
}
}
},
"auth_ref": [
"r99",
"r110",
"r126",
"r161"
]
},
"dei_ParentEntityLegalName": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "ParentEntityLegalName",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Parent Entity Legal Name",
"documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
}
}
},
"auth_ref": []
},
"ecd_PayVsPerformanceDisclosureLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "PayVsPerformanceDisclosureLineItems",
"lang": {
"en-us": {
"role": {
"label": "Pay vs Performance Disclosure [Line Items]",
"terseLabel": "Pay vs Performance Disclosure"
}
}
},
"auth_ref": [
"r132"
]
},
"ecd_PeerGroupIssuersFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "PeerGroupIssuersFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Peer Group Issuers, Footnote [Text Block]",
"terseLabel": "Peer Group Issuers, Footnote"
}
}
},
"auth_ref": [
"r142"
]
},
"ecd_PeerGroupTotalShareholderRtnAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "PeerGroupTotalShareholderRtnAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Peer Group Total Shareholder Return Amount",
"terseLabel": "Peer Group Total Shareholder Return Amount"
}
}
},
"auth_ref": [
"r142"
]
},
"ecd_PeoActuallyPaidCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "PeoActuallyPaidCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "PEO Actually Paid Compensation Amount",
"terseLabel": "PEO Actually Paid Compensation Amount"
}
}
},
"auth_ref": [
"r134"
]
},
"ecd_PeoMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "PeoMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "PEO [Member]",
"terseLabel": "PEO"
}
}
},
"auth_ref": [
"r151"
]
},
"ecd_PeoName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "PeoName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "PEO Name",
"terseLabel": "PEO Name"
}
}
},
"auth_ref": [
"r144"
]
},
"ecd_PeoTotalCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "PeoTotalCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "PEO Total Compensation Amount",
"terseLabel": "PEO Total Compensation Amount"
}
}
},
"auth_ref": [
"r133"
]
},
"dei_PhoneFaxNumberDescription": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "PhoneFaxNumberDescription",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Phone Fax Number Description",
"documentation": "Description of Phone or Fax Number"
}
}
},
"auth_ref": []
},
"ecd_PnsnAdjsPrrSvcCstMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "PnsnAdjsPrrSvcCstMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Pension Adjustments Prior Service Cost [Member]",
"terseLabel": "Pension Adjustments Prior Service Cost"
}
}
},
"auth_ref": [
"r135"
]
},
"ecd_PnsnAdjsSvcCstMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "PnsnAdjsSvcCstMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Pension Adjustments Service Cost [Member]",
"terseLabel": "Pension Adjustments Service Cost"
}
}
},
"auth_ref": [
"r180"
]
},
"ecd_PnsnBnftsAdjFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "PnsnBnftsAdjFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Pension Benefits Adjustments, Footnote [Text Block]",
"terseLabel": "Pension Benefits Adjustments, Footnote"
}
}
},
"auth_ref": [
"r134"
]
},
"dei_PostEffectiveAmendment": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "PostEffectiveAmendment",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Post-Effective Amendment"
}
}
},
"auth_ref": [
"r75"
]
},
"dei_PostEffectiveAmendmentNumber": {
"xbrltype": "sequenceNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "PostEffectiveAmendmentNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Post-Effective Amendment Number",
"documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
}
}
},
"auth_ref": [
"r75"
]
},
"dei_PreCommencementIssuerTenderOffer": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "PreCommencementIssuerTenderOffer",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Pre-commencement Issuer Tender Offer",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
}
}
},
"auth_ref": [
"r82"
]
},
"dei_PreCommencementTenderOffer": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "PreCommencementTenderOffer",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Pre-commencement Tender Offer",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
}
}
},
"auth_ref": [
"r84"
]
},
"dei_PreEffectiveAmendment": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "PreEffectiveAmendment",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Pre-Effective Amendment"
}
}
},
"auth_ref": [
"r75"
]
},
"dei_PreEffectiveAmendmentNumber": {
"xbrltype": "sequenceNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "PreEffectiveAmendmentNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Pre-Effective Amendment Number",
"documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
}
}
},
"auth_ref": [
"r75"
]
},
"vtgn_PriorYearEndFairValueOfEquityAwardsGrantedInAnyPriorYearModifiedDuringCoveredYearMember": {
"xbrltype": "domainItemType",
"nsuri": "http://www.vistagen.com/20250728",
"localname": "PriorYearEndFairValueOfEquityAwardsGrantedInAnyPriorYearModifiedDuringCoveredYearMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year Modified During Covered Year [Member]"
}
}
},
"auth_ref": []
},
"ecd_PvpTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "PvpTable",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Pay vs Performance Disclosure [Table]",
"terseLabel": "Pay vs Performance Disclosure"
}
}
},
"auth_ref": [
"r132"
]
},
"ecd_PvpTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "PvpTableTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Pay vs Performance [Table Text Block]",
"terseLabel": "Pay vs Performance Disclosure, Table"
}
}
},
"auth_ref": [
"r132"
]
},
"ecd_RecoveryOfErrCompDisclosureLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "RecoveryOfErrCompDisclosureLineItems",
"lang": {
"en-us": {
"role": {
"label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
"terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
}
}
},
"auth_ref": [
"r91",
"r102",
"r118",
"r153"
]
},
"dei_RegistrationStatementAmendmentNumber": {
"xbrltype": "sequenceNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "RegistrationStatementAmendmentNumber",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Registration Statement Amendment Number",
"documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
}
}
},
"auth_ref": [
"r75"
]
},
"ecd_RestatementDateAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "RestatementDateAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Restatement Determination Date [Axis]",
"terseLabel": "Restatement Determination Date:"
}
}
},
"auth_ref": [
"r92",
"r103",
"r119",
"r154"
]
},
"ecd_RestatementDeterminationDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "RestatementDeterminationDate",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Restatement Determination Date",
"terseLabel": "Restatement Determination Date"
}
}
},
"auth_ref": [
"r93",
"r104",
"r120",
"r155"
]
},
"ecd_RestatementDoesNotRequireRecoveryTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "RestatementDoesNotRequireRecoveryTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Restatement Does Not Require Recovery [Text Block]",
"terseLabel": "Restatement does not require Recovery"
}
}
},
"auth_ref": [
"r100",
"r111",
"r127",
"r162"
]
},
"ecd_Rule10b51ArrAdoptedFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "Rule10b51ArrAdoptedFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Rule 10b5-1 Arrangement Adopted [Flag]",
"terseLabel": "Rule 10b5-1 Arrangement Adopted"
}
}
},
"auth_ref": [
"r171"
]
},
"ecd_Rule10b51ArrTrmntdFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "Rule10b51ArrTrmntdFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Rule 10b5-1 Arrangement Terminated [Flag]",
"terseLabel": "Rule 10b5-1 Arrangement Terminated"
}
}
},
"auth_ref": [
"r171"
]
},
"dei_Security12bTitle": {
"xbrltype": "securityTitleItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "Security12bTitle",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Title of 12(b) Security",
"documentation": "Title of a 12(b) registered security."
}
}
},
"auth_ref": [
"r76"
]
},
"dei_Security12gTitle": {
"xbrltype": "securityTitleItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "Security12gTitle",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Title of 12(g) Security",
"documentation": "Title of a 12(g) registered security."
}
}
},
"auth_ref": [
"r80"
]
},
"dei_SecurityExchangeName": {
"xbrltype": "edgarExchangeCodeItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "SecurityExchangeName",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Security Exchange Name",
"documentation": "Name of the Exchange on which a security is registered."
}
}
},
"auth_ref": [
"r79"
]
},
"dei_SecurityReportingObligation": {
"xbrltype": "securityReportingObligationItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "SecurityReportingObligation",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Security Reporting Obligation",
"documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
}
}
},
"auth_ref": [
"r85"
]
},
"us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2025",
"localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "All Award Types",
"terseLabel": "All Award Types",
"documentation": "Award under share-based payment arrangement."
}
}
},
"auth_ref": [
"r35",
"r36",
"r37",
"r38",
"r39",
"r40",
"r41",
"r42",
"r43",
"r44",
"r45",
"r46",
"r47",
"r48",
"r49",
"r50",
"r51",
"r52",
"r53",
"r54",
"r55",
"r56",
"r57",
"r58",
"r59",
"r60"
]
},
"dei_SolicitingMaterial": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "SolicitingMaterial",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Soliciting Material",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
}
}
},
"auth_ref": [
"r83"
]
},
"ecd_StkPrcOrTsrEstimationMethodTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "StkPrcOrTsrEstimationMethodTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Stock Price or TSR Estimation Method [Text Block]",
"terseLabel": "Stock Price or TSR Estimation Method"
}
}
},
"auth_ref": [
"r95",
"r106",
"r122",
"r157"
]
},
"us-gaap_StockAppreciationRightsSARSMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2025",
"localname": "StockAppreciationRightsSARSMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Stock Appreciation Rights (SARs) [Member]",
"terseLabel": "Stock Appreciation Rights (SARs)",
"documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
}
}
},
"auth_ref": [
"r196",
"r197",
"r198",
"r199",
"r200",
"r201",
"r202",
"r203",
"r204",
"r205",
"r206",
"r207",
"r208",
"r209",
"r210",
"r211",
"r212",
"r213",
"r214",
"r215",
"r216",
"r217",
"r218",
"r219",
"r220",
"r221"
]
},
"ecd_TabularListTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "TabularListTableTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Tabular List [Table Text Block]",
"terseLabel": "Tabular List, Table"
}
}
},
"auth_ref": [
"r150"
]
},
"ecd_TotalShareholderRtnAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "TotalShareholderRtnAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Total Shareholder Return Amount",
"terseLabel": "Total Shareholder Return Amount"
}
}
},
"auth_ref": [
"r142"
]
},
"ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "TotalShareholderRtnVsPeerGroupTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Total Shareholder Return Vs Peer Group [Text Block]",
"terseLabel": "Total Shareholder Return Vs Peer Group"
}
}
},
"auth_ref": [
"r149"
]
},
"ecd_TradingArrAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "TradingArrAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Arrangement [Axis]",
"terseLabel": "Trading Arrangement:"
}
}
},
"auth_ref": [
"r170"
]
},
"ecd_TradingArrByIndTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "TradingArrByIndTable",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Arrangements, by Individual [Table]",
"terseLabel": "Trading Arrangements, by Individual"
}
}
},
"auth_ref": [
"r172"
]
},
"dei_TradingSymbol": {
"xbrltype": "tradingSymbolItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "TradingSymbol",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Symbol",
"documentation": "Trading symbol of an instrument as listed on an exchange."
}
}
},
"auth_ref": []
},
"ecd_TrdArrAdoptionDate": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "TrdArrAdoptionDate",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Arrangement Adoption Date",
"terseLabel": "Adoption Date"
}
}
},
"auth_ref": [
"r173"
]
},
"ecd_TrdArrDuration": {
"xbrltype": "durationItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "TrdArrDuration",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Arrangement Duration",
"terseLabel": "Arrangement Duration"
}
}
},
"auth_ref": [
"r174"
]
},
"ecd_TrdArrExpirationDate": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "TrdArrExpirationDate",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Arrangement Expiration Date",
"terseLabel": "Expiration Date"
}
}
},
"auth_ref": [
"r174"
]
},
"ecd_TrdArrIndName": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "TrdArrIndName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Arrangement, Individual Name",
"terseLabel": "Name"
}
}
},
"auth_ref": [
"r172"
]
},
"ecd_TrdArrIndTitle": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "TrdArrIndTitle",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Arrangement, Individual Title",
"terseLabel": "Title"
}
}
},
"auth_ref": [
"r172"
]
},
"ecd_TrdArrSecuritiesAggAvailAmt": {
"xbrltype": "sharesItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "TrdArrSecuritiesAggAvailAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Arrangement, Securities Aggregate Available Amount",
"terseLabel": "Aggregate Available"
}
}
},
"auth_ref": [
"r175"
]
},
"ecd_TrdArrTerminationDate": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "TrdArrTerminationDate",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Arrangement Termination Date",
"terseLabel": "Termination Date"
}
}
},
"auth_ref": [
"r173"
]
},
"ecd_UndrlygSecurityMktPriceChngPct": {
"xbrltype": "pureItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "UndrlygSecurityMktPriceChngPct",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Underlying Security Market Price Change, Percent",
"terseLabel": "Underlying Security Market Price Change"
}
}
},
"auth_ref": [
"r169"
]
},
"ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
"terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
}
}
},
"auth_ref": [
"r138"
]
},
"dei_WrittenCommunications": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "WrittenCommunications",
"presentation": [
"http://xbrl.sec.gov/dei/role/document/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Written Communications",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
}
}
},
"auth_ref": [
"r186"
]
},
"ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2025",
"localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
"terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
}
}
},
"auth_ref": [
"r136"
]
}
}
}
},
"std_ref": {
"r0": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03(20))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
},
"r1": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "230",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "28",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
},
"r2": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "942",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-04(22))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
},
"r3": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "105",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "9",
"Subparagraph": "(e)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
},
"r4": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "205",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
},
"r5": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "1A",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
},
"r6": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "1B",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
},
"r7": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
},
"r8": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S50",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
},
"r9": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(g)(1)(i))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
},
"r10": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(g)(1)(ii))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
},
"r11": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(k)(2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
},
"r12": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
},
"r13": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "11",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
},
"r14": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "11",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
},
"r15": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
},
"r16": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "4",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
},
"r17": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
},
"r18": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "8",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
},
"r19": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "9",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
},
"r20": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "260",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "60B",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
},
"r21": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "323",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
},
"r22": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(i))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
},
"r23": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
},
"r24": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(iv))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
},
"r25": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(5))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
},
"r26": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(4)(i))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
},
"r27": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
},
"r28": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
},
"r29": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(4)(iv))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
},
"r30": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(5))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
},
"r31": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "4",
"Subparagraph": "(f)(4)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
},
"r32": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "480",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S45",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
},
"r33": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "480",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
},
"r34": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "480",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3A",
"Subparagraph": "(24)(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
},
"r35": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r36": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r37": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r38": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r39": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(ii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r40": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r41": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r42": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(01)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r43": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(02)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r44": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(03)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r45": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(04)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r46": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r47": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(ii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r48": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(iii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r49": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(iii)(01)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r50": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(iii)(02)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r51": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(iii)(03)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r52": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(d)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r53": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(d)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r54": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(e)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r55": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(e)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r56": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r57": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(ii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r58": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(iii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r59": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(iv)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r60": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(v)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r61": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "17",
"Subparagraph": "(d)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
},
"r62": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "323",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(g)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
},
"r63": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "805",
"SubTopic": "60",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "1",
"Subparagraph": "(g)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
},
"r64": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "815",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "1",
"Subparagraph": "(f)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
},
"r65": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "825",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "28",
"Subparagraph": "(f)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
},
"r66": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-04(18))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
},
"r67": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "7",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
},
"r68": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(9))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
},
"r69": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.6-09(1)(d))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
},
"r70": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "220",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "14",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
},
"r71": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "220",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "21",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
},
"r72": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "220",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "4",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
},
"r73": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "830",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "10",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
},
"r74": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "Global LEI Foundation"
},
"r75": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12"
},
"r76": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "b"
},
"r77": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "b-2"
},
"r78": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "b-23"
},
"r79": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "d1-1"
},
"r80": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "g"
},
"r81": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12, 13, 15d"
},
"r82": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "13e",
"Subsection": "4c"
},
"r83": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "14a",
"Subsection": "12"
},
"r84": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "14d",
"Subsection": "2b"
},
"r85": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "15",
"Subsection": "d"
},
"r86": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 10-K",
"Number": "249",
"Section": "310"
},
"r87": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 10-Q",
"Number": "240",
"Section": "308",
"Subsection": "a"
},
"r88": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 10-Q",
"Number": "249",
"Section": "308",
"Subsection": "a"
},
"r89": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Number": "249",
"Section": "220",
"Subsection": "f"
},
"r90": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "16",
"Subsection": "J",
"Paragraph": "a"
},
"r91": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1"
},
"r92": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "i"
},
"r93": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "A"
},
"r94": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "B"
},
"r95": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "C"
},
"r96": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "D"
},
"r97": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "E"
},
"r98": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "ii"
},
"r99": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "iii"
},
"r100": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "2"
},
"r101": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Number": "249",
"Section": "240",
"Subsection": "f"
},
"r102": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a"
},
"r103": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "1"
},
"r104": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "i"
},
"r105": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "ii"
},
"r106": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "iii"
},
"r107": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "iv"
},
"r108": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "v"
},
"r109": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "2"
},
"r110": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "3"
},
"r111": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "b"
},
"r112": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 8-K",
"Number": "249",
"Section": "308"
},
"r113": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form F-3"
},
"r114": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-2"
},
"r115": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-3"
},
"r116": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-4"
},
"r117": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-6"
},
"r118": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a"
},
"r119": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "1"
},
"r120": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "i"
},
"r121": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "ii"
},
"r122": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "iii"
},
"r123": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "iv"
},
"r124": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "v"
},
"r125": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "2"
},
"r126": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "3"
},
"r127": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "b"
},
"r128": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form S-3"
},
"r129": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Forms 10-K, 10-Q, 20-F",
"Number": "240",
"Section": "13",
"Subsection": "a-1"
},
"r130": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Investment Company Act",
"Number": "270"
},
"r131": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v"
},
"r132": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "1"
},
"r133": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "ii"
},
"r134": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iii"
},
"r135": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iii",
"Sentence": "B",
"Clause": "1",
"Subclause": "ii"
},
"r136": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iii",
"Sentence": "C",
"Clause": "1",
"Subclause": "i"
},
"r137": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iii",
"Sentence": "C",
"Clause": "1",
"Subclause": "ii"
},
"r138": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iii",
"Sentence": "C",
"Clause": "1",
"Subclause": "iii"
},
"r139": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iii",
"Sentence": "C",
"Clause": "1",
"Subclause": "iv"
},
"r140": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iii",
"Sentence": "C",
"Clause": "1",
"Subclause": "v"
},
"r141": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iii",
"Sentence": "C",
"Clause": "1",
"Subclause": "vi"
},
"r142": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iv"
},
"r143": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "vi"
},
"r144": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "3"
},
"r145": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "4"
},
"r146": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "5",
"Subparagraph": "i"
},
"r147": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "5",
"Subparagraph": "ii"
},
"r148": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "5",
"Subparagraph": "iii"
},
"r149": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "5",
"Subparagraph": "iv"
},
"r150": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "6"
},
"r151": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "6",
"Subparagraph": "i"
},
"r152": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w"
},
"r153": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1"
},
"r154": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "i"
},
"r155": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "A"
},
"r156": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "B"
},
"r157": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "C"
},
"r158": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "D"
},
"r159": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "E"
},
"r160": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "ii"
},
"r161": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "iii"
},
"r162": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "2"
},
"r163": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "1"
},
"r164": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "2"
},
"r165": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "2",
"Subparagraph": "ii",
"Sentence": "A"
},
"r166": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "2",
"Subparagraph": "ii",
"Sentence": "C"
},
"r167": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "2",
"Subparagraph": "ii",
"Sentence": "D"
},
"r168": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "2",
"Subparagraph": "ii",
"Sentence": "E"
},
"r169": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "2",
"Subparagraph": "ii",
"Sentence": "F"
},
"r170": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "a"
},
"r171": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "a",
"Paragraph": "1"
},
"r172": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "a",
"Paragraph": "2",
"Subparagraph": "A"
},
"r173": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "a",
"Paragraph": "2",
"Subparagraph": "B"
},
"r174": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "a",
"Paragraph": "2",
"Subparagraph": "C"
},
"r175": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "a",
"Paragraph": "2",
"Subparagraph": "D"
},
"r176": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "b",
"Paragraph": "1"
},
"r177": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Section": "402",
"Number": "229",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iii",
"Sentence": "C",
"Clause": "1"
},
"r178": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iii",
"Sentence": "A",
"Number": "229"
},
"r179": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iii",
"Sentence": "B",
"Clause": "1",
"Number": "229"
},
"r180": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iii",
"Sentence": "B",
"Clause": "1",
"Subclause": "i",
"Number": "229"
},
"r181": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-T",
"Number": "232",
"Section": "313"
},
"r182": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-T",
"Number": "232",
"Section": "405"
},
"r183": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-X",
"Number": "210",
"Section": "2",
"Subsection": "2"
},
"r184": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "405"
},
"r185": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "413",
"Subsection": "b"
},
"r186": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "425"
},
"r187": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "462",
"Subsection": "b"
},
"r188": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "462",
"Subsection": "c"
},
"r189": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "462",
"Subsection": "d"
},
"r190": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "462",
"Subsection": "e"
},
"r191": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "486",
"Subsection": "a"
},
"r192": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "486",
"Subsection": "b"
},
"r193": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "7A",
"Section": "B",
"Subsection": "2"
},
"r194": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Section": "8",
"Subsection": "c"
},
"r195": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(ii))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
},
"r196": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r197": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r198": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r199": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r200": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(ii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r201": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r202": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r203": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(01)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r204": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(02)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r205": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(03)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r206": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(04)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r207": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r208": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(ii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r209": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(iii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r210": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(iii)(01)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r211": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(iii)(02)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r212": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(iii)(03)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r213": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(d)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r214": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(d)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r215": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(e)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r216": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(e)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r217": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r218": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(ii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r219": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(iii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r220": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(iv)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
},
"r221": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(v)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
}
}
}